WO2016012515A2 - Emulsions stabilized with a crosslinked silicone polymer and a semi-crystalline polymer - Google Patents
Emulsions stabilized with a crosslinked silicone polymer and a semi-crystalline polymer Download PDFInfo
- Publication number
- WO2016012515A2 WO2016012515A2 PCT/EP2015/066796 EP2015066796W WO2016012515A2 WO 2016012515 A2 WO2016012515 A2 WO 2016012515A2 EP 2015066796 W EP2015066796 W EP 2015066796W WO 2016012515 A2 WO2016012515 A2 WO 2016012515A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- composition
- composition according
- semi
- chain
- Prior art date
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 50
- 229920006126 semicrystalline polymer Polymers 0.000 title claims abstract description 50
- 229920005573 silicon-containing polymer Polymers 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 144
- 239000012071 phase Substances 0.000 claims abstract description 28
- 239000008346 aqueous phase Substances 0.000 claims abstract description 15
- -1 polyoxypropylene chain Polymers 0.000 claims description 61
- 229920002379 silicone rubber Polymers 0.000 claims description 45
- 239000003921 oil Substances 0.000 claims description 36
- 229920000642 polymer Polymers 0.000 claims description 34
- 229920001577 copolymer Polymers 0.000 claims description 33
- 239000000178 monomer Substances 0.000 claims description 30
- 125000000217 alkyl group Chemical group 0.000 claims description 29
- 125000004432 carbon atom Chemical group C* 0.000 claims description 29
- 239000002537 cosmetic Substances 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 28
- 229930195733 hydrocarbon Natural products 0.000 claims description 17
- 238000012216 screening Methods 0.000 claims description 17
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 16
- 239000004215 Carbon black (E152) Substances 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 150000002430 hydrocarbons Chemical class 0.000 claims description 15
- 239000003054 catalyst Substances 0.000 claims description 14
- 229920001519 homopolymer Polymers 0.000 claims description 14
- 238000006116 polymerization reaction Methods 0.000 claims description 14
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 13
- 239000002671 adjuvant Substances 0.000 claims description 13
- 125000001931 aliphatic group Chemical group 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- 210000004209 hair Anatomy 0.000 claims description 11
- 230000002209 hydrophobic effect Effects 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000000049 pigment Substances 0.000 claims description 10
- 102000011782 Keratins Human genes 0.000 claims description 9
- 108010076876 Keratins Proteins 0.000 claims description 9
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 9
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 8
- 238000007334 copolymerization reaction Methods 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000000963 oxybis(methylene) group Chemical group [H]C([H])(*)OC([H])([H])* 0.000 claims description 8
- 239000002562 thickening agent Substances 0.000 claims description 7
- 229910004674 SiO0.5 Inorganic materials 0.000 claims description 6
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 6
- 238000006459 hydrosilylation reaction Methods 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 230000000699 topical effect Effects 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 4
- 238000011200 topical administration Methods 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 239000003349 gelling agent Substances 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 229920001451 polypropylene glycol Polymers 0.000 claims description 3
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 claims description 3
- 239000006096 absorbing agent Substances 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 239000003899 bactericide agent Substances 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 239000008139 complexing agent Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 239000000417 fungicide Substances 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 2
- 230000003020 moisturizing effect Effects 0.000 claims description 2
- 230000000590 parasiticidal effect Effects 0.000 claims description 2
- 239000002297 parasiticide Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 28
- 235000019198 oils Nutrition 0.000 description 23
- 239000000499 gel Substances 0.000 description 19
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical group [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 16
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 14
- 230000000694 effects Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 10
- 229920001296 polysiloxane Polymers 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 229920001971 elastomer Polymers 0.000 description 9
- 239000000806 elastomer Substances 0.000 description 9
- 125000001153 fluoro group Chemical group F* 0.000 description 9
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- 239000001993 wax Substances 0.000 description 9
- 239000011149 active material Substances 0.000 description 8
- 229920001400 block copolymer Polymers 0.000 description 8
- 229940008099 dimethicone Drugs 0.000 description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 239000007764 o/w emulsion Substances 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 6
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 229920006037 cross link polymer Polymers 0.000 description 6
- 230000001804 emulsifying effect Effects 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000007762 w/o emulsion Substances 0.000 description 6
- 239000004912 1,5-cyclooctadiene Substances 0.000 description 5
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 5
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 5
- 125000005250 alkyl acrylate group Chemical group 0.000 description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N aniline-p-carboxylic acid Natural products NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 229910052697 platinum Inorganic materials 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 description 5
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 4
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 4
- 229940126062 Compound A Drugs 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 235000013980 iron oxide Nutrition 0.000 description 4
- 229920000098 polyolefin Polymers 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 4
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 3
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 3
- VEPKQEUBKLEPRA-UHFFFAOYSA-N VX-745 Chemical compound FC1=CC(F)=CC=C1SC1=NN2C=NC(=O)C(C=3C(=CC=CC=3Cl)Cl)=C2C=C1 VEPKQEUBKLEPRA-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000000304 alkynyl group Chemical group 0.000 description 3
- 150000001412 amines Chemical group 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- MNWFXJYAOYHMED-UHFFFAOYSA-N hexane carboxylic acid Natural products CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 3
- 235000011837 pasties Nutrition 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000006068 polycondensation reaction Methods 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 235000010215 titanium dioxide Nutrition 0.000 description 3
- 229920001567 vinyl ester resin Polymers 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 239000004711 α-olefin Substances 0.000 description 3
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 2
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 2
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229910020381 SiO1.5 Inorganic materials 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000003926 acrylamides Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229910052681 coesite Inorganic materials 0.000 description 2
- 229910052906 cristobalite Inorganic materials 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- IAJNXBNRYMEYAZ-UHFFFAOYSA-N ethyl 2-cyano-3,3-diphenylprop-2-enoate Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC)C1=CC=CC=C1 IAJNXBNRYMEYAZ-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- CKFGINPQOCXMAZ-UHFFFAOYSA-N methanediol Chemical compound OCO CKFGINPQOCXMAZ-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- 229920001921 poly-methyl-phenyl-siloxane Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910052682 stishovite Inorganic materials 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229910052905 tridymite Inorganic materials 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- VYXHVRARDIDEHS-UHFFFAOYSA-N 1,5-cyclooctadiene Chemical compound C1CC=CCCC=C1 VYXHVRARDIDEHS-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- NWGAAWUUGRXXSC-UHFFFAOYSA-N 1-(2-hydroxypropoxy)propan-2-yl 2-hydroxybenzoate Chemical compound CC(O)COCC(C)OC(=O)C1=CC=CC=C1O NWGAAWUUGRXXSC-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- 229940106006 1-eicosene Drugs 0.000 description 1
- FIKTURVKRGQNQD-UHFFFAOYSA-N 1-eicosene Natural products CCCCCCCCCCCCCCCCCC=CC(O)=O FIKTURVKRGQNQD-UHFFFAOYSA-N 0.000 description 1
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- RWKSBJVOQGKDFZ-UHFFFAOYSA-N 16-methylheptadecyl 2-hydroxypropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)O RWKSBJVOQGKDFZ-UHFFFAOYSA-N 0.000 description 1
- HECLRDQVFMWTQS-RGOKHQFPSA-N 1755-01-7 Chemical compound C1[C@H]2[C@@H]3CC=C[C@@H]3[C@@H]1C=C2 HECLRDQVFMWTQS-RGOKHQFPSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- GJUXFTUISAQMQE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate;2,3-dimethoxy-3-phenylprop-2-enoic acid Chemical compound CCCCC(CC)C(=O)OCC(O)CO.COC(C(O)=O)=C(OC)C1=CC=CC=C1 GJUXFTUISAQMQE-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- FWIUBOWVXREPPL-UHFFFAOYSA-N 2-[2-(7-methyloctanoyloxy)ethoxy]ethyl 7-methyloctanoate Chemical compound CC(C)CCCCCC(=O)OCCOCCOC(=O)CCCCCC(C)C FWIUBOWVXREPPL-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- WHNBDXQTMPYBAT-UHFFFAOYSA-N 2-butyloxirane Chemical compound CCCCC1CO1 WHNBDXQTMPYBAT-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- NJWSNNWLBMSXQR-UHFFFAOYSA-N 2-hexyloxirane Chemical compound CCCCCCC1CO1 NJWSNNWLBMSXQR-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- CNPVJWYWYZMPDS-UHFFFAOYSA-N 2-methyldecane Chemical compound CCCCCCCCC(C)C CNPVJWYWYZMPDS-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- WRUPARRPRIVURX-MRCUWXFGSA-N 2-octyldodecyl (z)-docos-13-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCCCCCC\C=C/CCCCCCCC WRUPARRPRIVURX-MRCUWXFGSA-N 0.000 description 1
- PTPDZZWUOHQSLG-UHFFFAOYSA-N 2-octyldodecyl 2,2-dimethylpropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)(C)C)CCCCCCCC PTPDZZWUOHQSLG-UHFFFAOYSA-N 0.000 description 1
- HXVCOQUDJKMJQY-UHFFFAOYSA-N 2-octyldodecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC HXVCOQUDJKMJQY-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- UDOJACSDSIHAAT-UHFFFAOYSA-N 5-benzylbicyclo[2.2.1]hept-2-ene Chemical compound C1C(C=C2)CC2C1CC1=CC=CC=C1 UDOJACSDSIHAAT-UHFFFAOYSA-N 0.000 description 1
- INYHZQLKOKTDAI-UHFFFAOYSA-N 5-ethenylbicyclo[2.2.1]hept-2-ene Chemical compound C1C2C(C=C)CC1C=C2 INYHZQLKOKTDAI-UHFFFAOYSA-N 0.000 description 1
- QHJIJNGGGLNBNJ-UHFFFAOYSA-N 5-ethylbicyclo[2.2.1]hept-2-ene Chemical compound C1C2C(CC)CC1C=C2 QHJIJNGGGLNBNJ-UHFFFAOYSA-N 0.000 description 1
- OJOWICOBYCXEKR-UHFFFAOYSA-N 5-ethylidenebicyclo[2.2.1]hept-2-ene Chemical compound C1C2C(=CC)CC1C=C2 OJOWICOBYCXEKR-UHFFFAOYSA-N 0.000 description 1
- PCBPVYHMZBWMAZ-UHFFFAOYSA-N 5-methylbicyclo[2.2.1]hept-2-ene Chemical compound C1C2C(C)CC1C=C2 PCBPVYHMZBWMAZ-UHFFFAOYSA-N 0.000 description 1
- PGNNHYNYFLXKDZ-UHFFFAOYSA-N 5-phenylbicyclo[2.2.1]hept-2-ene Chemical compound C1=CC2CC1CC2C1=CC=CC=C1 PGNNHYNYFLXKDZ-UHFFFAOYSA-N 0.000 description 1
- JTHZUSWLNCPZLX-UHFFFAOYSA-N 6-fluoro-3-methyl-2h-indazole Chemical compound FC1=CC=C2C(C)=NNC2=C1 JTHZUSWLNCPZLX-UHFFFAOYSA-N 0.000 description 1
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 description 1
- LVGFPWDANALGOY-UHFFFAOYSA-N 8-methylnonyl prop-2-enoate Chemical compound CC(C)CCCCCCCOC(=O)C=C LVGFPWDANALGOY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229920001634 Copolyester Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 241000197727 Euscorpius alpha Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920003354 Modic® Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 1
- HEAHZSUCFKFERC-IWGRKNQJSA-N [(2e)-2-[[4-[(e)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical group CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C\C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-IWGRKNQJSA-N 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- ADANNTOYRVPQLJ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-[[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilyl]oxy-dimethylsilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C ADANNTOYRVPQLJ-UHFFFAOYSA-N 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960002709 amiloxate Drugs 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- OHXVIZBSLGZEFS-UHFFFAOYSA-N benzhydrylsilyloxy-diphenyl-silyloxysilane Chemical class C1(=CC=CC=C1)C(C1=CC=CC=C1)[SiH2]O[Si](O[SiH3])(C1=CC=CC=C1)C1=CC=CC=C1 OHXVIZBSLGZEFS-UHFFFAOYSA-N 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229940111759 benzophenone-2 Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- PXTQQOLKZBLYDY-UHFFFAOYSA-N bis(2-ethylhexyl) carbonate Chemical compound CCCCC(CC)COC(=O)OCC(CC)CCCC PXTQQOLKZBLYDY-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- FSIJKGMIQTVTNP-UHFFFAOYSA-N bis(ethenyl)-methyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C=C)C=C FSIJKGMIQTVTNP-UHFFFAOYSA-N 0.000 description 1
- 238000012661 block copolymerization Methods 0.000 description 1
- 229940067573 brown iron oxide Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical group 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- QFSKIUZTIHBWFR-UHFFFAOYSA-N chromium;hydrate Chemical compound O.[Cr] QFSKIUZTIHBWFR-UHFFFAOYSA-N 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229960001063 cinoxate Drugs 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000001925 cycloalkenes Chemical class 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- ZWAJLVLEBYIOTI-UHFFFAOYSA-N cyclohexene oxide Chemical compound C1CCCC2OC21 ZWAJLVLEBYIOTI-UHFFFAOYSA-N 0.000 description 1
- FWFSEYBSWVRWGL-UHFFFAOYSA-N cyclohexene oxide Natural products O=C1CCCC=C1 FWFSEYBSWVRWGL-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- URYYVOIYTNXXBN-UPHRSURJSA-N cyclooctene Chemical compound C1CCC\C=C/CC1 URYYVOIYTNXXBN-UPHRSURJSA-N 0.000 description 1
- 239000004913 cyclooctene Substances 0.000 description 1
- 125000005534 decanoate group Chemical class 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical group [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- KHAYCTOSKLIHEP-UHFFFAOYSA-N docosyl prop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCOC(=O)C=C KHAYCTOSKLIHEP-UHFFFAOYSA-N 0.000 description 1
- 229940087203 dodecamethylpentasiloxane Drugs 0.000 description 1
- FBZANXDWQAVSTQ-UHFFFAOYSA-N dodecamethylpentasiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C FBZANXDWQAVSTQ-UHFFFAOYSA-N 0.000 description 1
- ANXXYABAFAQBOT-UHFFFAOYSA-N dodecyl-methyl-bis(trimethylsilyloxy)silane Chemical compound CCCCCCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C ANXXYABAFAQBOT-UHFFFAOYSA-N 0.000 description 1
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- BHXIWUJLHYHGSJ-UHFFFAOYSA-N ethyl 3-ethoxypropanoate Chemical compound CCOCCC(=O)OCC BHXIWUJLHYHGSJ-UHFFFAOYSA-N 0.000 description 1
- CBZHHQOZZQEZNJ-UHFFFAOYSA-N ethyl 4-[bis(2-hydroxypropyl)amino]benzoate Chemical compound CCOC(=O)C1=CC=C(N(CC(C)O)CC(C)O)C=C1 CBZHHQOZZQEZNJ-UHFFFAOYSA-N 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N ethyl ethylene Natural products CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- XWRLQRLQUKZEEU-UHFFFAOYSA-N ethyl(hydroxy)silicon Chemical class CC[Si]O XWRLQRLQUKZEEU-UHFFFAOYSA-N 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 125000003709 fluoroalkyl group Chemical group 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- NFVSFLUJRHRSJG-UHFFFAOYSA-N hexadecamethylheptasiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C NFVSFLUJRHRSJG-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 150000004687 hexahydrates Chemical group 0.000 description 1
- HTDJPCNNEPUOOQ-UHFFFAOYSA-N hexamethylcyclotrisiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1 HTDJPCNNEPUOOQ-UHFFFAOYSA-N 0.000 description 1
- PNJMJEXVQAFSBS-UHFFFAOYSA-N hexyl-methyl-bis(trimethylsilyloxy)silane Chemical compound CCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C PNJMJEXVQAFSBS-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- LTYSCLBTUYRCBF-UHFFFAOYSA-N icosan-9-yl 2-hydroxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)OC(CCCCCCCC)CCCCCCCCCCC LTYSCLBTUYRCBF-UHFFFAOYSA-N 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- PVWXTVUZGJXFJQ-CCEZHUSRSA-N methyl (E)-4-methyl-3-phenyl-2-propan-2-ylpent-2-enoate Chemical compound COC(=O)C(\C(C)C)=C(/C(C)C)C1=CC=CC=C1 PVWXTVUZGJXFJQ-CCEZHUSRSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 229940117969 neopentyl glycol Drugs 0.000 description 1
- JFNLZVQOOSMTJK-UHFFFAOYSA-N norbornene Chemical compound C1C2CCC1C=C2 JFNLZVQOOSMTJK-UHFFFAOYSA-N 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadecene Natural products CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 description 1
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 125000005474 octanoate group Chemical class 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940048862 octyldodecyl neopentanoate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000011146 organic particle Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GOZDOXXUTWHSKU-UHFFFAOYSA-N pentadecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCCCOC(=O)C=C GOZDOXXUTWHSKU-UHFFFAOYSA-N 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 150000003057 platinum Chemical class 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000059 polyethylene glycol stearate Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940095050 propylene Drugs 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical group [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003440 styrenes Chemical group 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 150000003512 tertiary amines Chemical group 0.000 description 1
- 229940008424 tetradecamethylhexasiloxane Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- DHWLRNPWPABRBG-UHFFFAOYSA-N tridecyl 2,2-dimethylpropanoate Chemical compound CCCCCCCCCCCCCOC(=O)C(C)(C)C DHWLRNPWPABRBG-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000000725 trifluoropropyl group Chemical group [H]C([H])(*)C([H])([H])C(F)(F)F 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the invention relates to a composition in the form of an oil-in-water or a water-in-oil emulsion type.
- a cosmetic composition in the form of an oil-in-water or a water-in-oil emulsion type.
- Said cosmetic composition is in particular intended to be applied to keratin materials, in particular the skin and the lips, the hair and the nails.
- the invention relates to a cosmetic composition which is in the form of an emulsion, comprising at least one silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain and one semi-crystalline polymer.
- emulsions containing at least one silicone elastomer are very advantageous for their application properties (particularly the slippery effect) and their very characteristic sensory effect (in particular, the provision of softness and the silky effect).
- document FR 2912 651 describes a composition in the form of a water-in-oil (W/O) emulsion containing at least one emulsifying silicone elastomer and at least one semi-crystalline polymer, providing a freshness effect during application and a very effective skin nutrition.
- W/O water-in-oil
- these compositions exhibit medium stability in the presence of organic oils or of sunscreens.
- the application qualities of these emulsions could be improved.
- the formulation perimeter is restricted, since these emulsions are limited to only water-in-oil emulsions.
- silicone emulsions are not persistent and do not always provide good wear of the effects during the day. As it happens, the wear qualities are essential for ensuring the effectiveness of the active molecules, and maintaining moisturization, comfort, emollience and photoprotective properties, when the emulsion contains screening agents.
- the emulsions according to the invention exhibit uniform application qualities and good comfort, and persistent properties over time, and exhibit good sensory attractiveness.
- stable is intended to mean stable for at least one month, preferably at least 2 months, at 45°C.
- the invention relates to a composition in the form of an emulsion comprising at least:
- said composition is a cosmetic composition.
- Said cosmetic composition is in particular suitable for topical application.
- the composition may be intended to be applied to keratin materials, in particular the skin and the lips, the hair and the nails.
- the invention relates to a cosmetic use of a composition according to the invention, for caring for keratin materials, preferably the skin, the lips, the hair and the nails.
- the invention relates to a method for the cosmetic treatment of keratin materials, comprising a topical admimstration of a composition according to the invention.
- the invention relates to a method for preparing a composition comprising at least:
- the inventors have developed emulsions based on at least one specific crosslinked silicone polymer, as emulsifier, and on at least one semi-crystalline polymer, which make it possible to obtain, after application, a feeling of softness, a good penetration quality, an absence of sensation of a residual oily or greasy effect, good stability and therefore good comfort immediately and over time.
- the effects observed are obtained both with water-in-oil (W/O) emulsions and with oil -in- water (O/W) emulsions.
- W/O water-in-oil
- O/W oil -in- water
- compositions according to the invention are intended for topical application to the skin or skin appendages, they contain a physiologically acceptable medium.
- physiologically acceptable medium'' is intended to mean a medium compatible with the skin, the lips, the mucous membranes, the nails, the scalp and/or the hair.
- a composition according to the invention must not contain compounds known to be toxic to human beings or animals.
- the aqueous phase comprises water and optionally at least one organic solvent which is water-miscible at ambient temperature (25°C) and/or at least one hydrophilic adjuvant
- adjuvant is intended to mean an active agent or additive, known in the prior art to have a physical, chemical and/or biological property of interest in the context of skincare, dermatology, cosmetics and/or makeup.
- water-miscible organic solvent mention may be made, in a non-limiting way, of in particular monoalcohols comprising from 2 to 8, preferably from 2 to 6 carbon atoms, such as ethanol, propanol, isopropanol, butanol, isobutanol, pentanol, hexanol, polyols having in particular from 2 to 20 carbon atoms, for instance glycerol, arabitol, adonitol, dulcitol, erythritol, pentylene glycol, propylene glycol, butylene glycol, isoprene glycol, hexylene glycol, (Methylene glycol, dipropylene glycol, polyglycerols with 2 to 6 glycerolated units, such as diglycerol, sorbitol; sugars such as glucose, fructose, maltose, lactose, sucrose, saccharose, xylose or trehalose
- composition may also contain thickening hydrophilic polymers such as homopolymers and copolymers of AMPS (for instance Hostacerin AMPS sold by the company Clariant), celluloses or acrylic polymers (such as carbopols, etc).
- hydrophilic polymers such as homopolymers and copolymers of AMPS (for instance Hostacerin AMPS sold by the company Clariant), celluloses or acrylic polymers (such as carbopols, etc).
- the oily phase consists of at least one oil or of any other fatty substance and lipophilic constituent which may be present in the composition of the invention, including the crosslinked silicone polymer. Any cosmetically acceptable oil may be used.
- oil is intended to mean a fatty substance that is liquid at ambient temperature (25°C).
- oils that may be used in the composition of the invention, examples that may be mentioned include:
- hydrocarbon-based oils of animal origin such as perhydrosqualene and squalane
- oils of vegetable origin such as liquid triglycerides of C 4 - C 10 fatty acids, for instance heptanoic or octanoic acid triglycerides, caprylic/capric acid triglycerides, for instance those sold by the company Stearineries Dubois or those available under the trade names Miglyol 810, Miglyol 812 and Miglyol 818 from the company Dynamit Nobel, or else, for example, sunflower oil, corn oil, soya bean oil, marrow oil, grape seed oil, sesame oil, hazelnut oil, apricot oil, macadamia oil, castor oil, avocado oil, jojoba oil and shea butter oil; - synthetic esters and ethers, in particular of fatty acids, for instance the oils of formulae R 1 COOR 2 and R 1 OR 2 in which Ri represents a C 8 to C 29 fatty acid residue and R 2 represents a C 3 to C 30 branched or unbranched or unbranched or
- hydrocarbons of mineral or synthetic origin such as volatile or non-volatile liquid paraffins, and derivatives thereof, petroleum jelly, polydecenes, and hydrogenated polyisobutene such as Parleam oil;
- PDMSs containing a linear or cyclic silicone chain, which are liquid or pasty at ambient temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexasUoxane and cyclopentasiloxane; polydimethylsiloxanes (or dimethicones) comprising alkyl, alkoxy or phenyl groups, which are pendant or at the end of a silicone chain, these groups containing from 2 to 24 carbon atoms; phenylsilicones, for instance phenyl trimethicones, phenyl dimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl dimethicones, diphenylmethyldiphenyltrisiloxanes, 2-phenylethyl trimethylsiloxysilicates and polymethylphenylsiloxanes;
- cyclopolydimethylsiloxanes cycl
- hydrocarbon-based oil is intended to mean any oil mainly comprising carbon and hydrogen atoms, and optionally ester, ether, fluoro, carboxylic acid and/or alcohol groups.
- the composition of the invention may contain other fatty substances in the oily phase, such as C 8 to C 30 fatty acids, for instance stearic acid; silicone resins such as trifluoromethyl(C 1 -C 4 alkyl) dimethicone and trifluoropropyl dimethicone; silicone gums (dimethiconol), non-emulsifying silicone elastomers, for instance the products sold under the names KSG 6 and KSG 16 by the company Shin-Etsu, under the names Trefll, BY29 and EPSX by the company Dow Corning, or under the name Gransil by the company Grant Industries; waxes, for example mineral waxes, waxes of animal origin, for instance beeswax, waxes of plant origin, hydrogenated oils
- the oily phase may contain one or more waxes chosen from those described above, and in particular a synthetic wax such as polymethylene wax or polyethylene wax, or alternatively one or more pasty fatty compounds such as petroleum jelly.
- the term "pasty compound'' is intended to mean a compound that is water-immiscible and that undergoes a reversible solid/liquid change of state and that comprises in the solid state an anisotropic crystal organization, and comprises, at a temperature of 23°C, a liquid fraction and a solid fraction.
- the oily phase may also comprise one or more lipophilic adjuvant(s), such as, for example, one or more oily thickeners.
- organomodified clays which are clays treated with compounds chosen in particular from quaternary amines and tertiary amines.
- Organomodified clays that may be mentioned include organomodified bentonites such as those which are commercially available under the name Bentone from the company Rheox, for instance those modified with distearyldimethylammonium chloride (Bentone 38 and Bentone 34), or the product modified with stearylbenzyldimethylammonium chloride (Bentone 27).
- the oily-phase thickener may advantageously be chosen from C 8 - C 30 fatty acid esters of glycerol, and in particular C 8 -C 30 fatty acid triesters of glycerol, such as glyceryl tristearate (tristearine), such as the mixture of acetylated glycol stearate and of glyceryl tristearate, sold under the name Unitwix by the company United Guardian.
- the oily-phase thickener may also be chosen from C 8 -C 30 fatty acid esters of dextrin, such as, in particular, dextrin palmitate, in particular those sold under the name Rheopearl by the company Chiba Flour Milling.
- the thickeners may be present in an amount ranging, for example, from approximately 0.1% to 5% by weight, preferably approximately 0.1% to 3% by weight and preferably approximately 0.2% to 2% by weight, relative to the total weight of the composition.
- the aqueous phase when the composition is in the form of an oil-in-water emulsion, may represent approximately 60% to 98% by weight, preferably approximately 65% to 95% by weight, preferably approximately 70% to 90% by weight and preferably approximately 70% to 85% by weight, relative to the total weight of the composition.
- the hydrophilic adjuvant(s), for instance the polyols and the monoalcohols, may represent approximately 0% to 30% by weight, preferably approximately 0.1% to 30% by weight, and preferably approximately 1% to 20% by weight, relative to the total weight of the composition.
- the water may be present in a content ranging from 60% to 98% by weight, preferably from 65% to 95% by weight, preferably approximately 70% to 90% by weight and preferably approximately 70% to 85% by weight, relative to the total weight of the composition.
- the oily phase within the composition in the form of an oil-in-water emulsion, represents a value less than or equal to approximately 35% by weight, preferably a value less than or equal to approximately 33% by weight, preferably a value less than or equal to approximately 32% by weight, relative to the total weight of the composition.
- the oily phase may represent approximately 2% to 35% by weight, preferably approximately 5% to 33% by weight, preferably approximately 10% to 33% by weight and preferably approximately 15% to 30% by weight, relative to the total weight of the composition.
- a composition in the form of an oil-in-water emulsion comprises an oil(s) content of less than or equal to approximately 35% by weight, preferably less than or equal to approximately 33% by weight and preferably less than or equal to 32% by weight, relative to the total weight of the composition.
- the aqueous phase when the composition is in the form of a water-in-oil W/O emulsion, may represent approximately 30% to 95% by weight, preferably approximately 35% to 90% by weight and preferably approximately 40% to 85% by weight, relative to the total weight of the composition.
- the water preferably represents at least approximately 30% by weight, preferably at least approximately 40% by weight, preferably at least approximately 50% by weight, relative to the total weight of the composition.
- This amount may represent, for example, approximately 30% to 90% by weight, preferably approximately 40% to 80% by weight and preferably approximately 50% to 75% by weight, relative to the total weight of the composition.
- the oily phase represents approximately 0.5% to 50% by weight, relative to the total weight of the composition, preferably approximately 10% to 35% by weight, relative to the total weight of the composition.
- Crosslinked silicone polymer
- a crosslinked silicone polymer is in particular described in PCT international application WO 2010/080755.
- the crosslinked silicone polymer in particular in the form of an organic silicone elastomer gel, contains an organic silicone elastomer and a hydrophobic liquid carrier.
- the organic silicone elastomer may represent approximately 2% to 95% by weight, relative to the total weight of the elastomer gel, while the hydrophobic liquid carrier may represent approximately 5% to 98% by weight, relative to the total weight of the elastomer gel.
- Additional constituents in addition to the organic silicone elastomer and the hydrophobic liquid carrier, may be added to the organic silicone elastomer gel; in this case, the amounts of all the constituents used must correspond exactly to 100% by weight.
- the silicone elastomer gel comprises: - 2% to 95% by weight, relative to the total weight of the silicone elastomer gel, of an organic silicone elastomer, obtained by reacting:
- R 1 represents a hydrogen or R 2 ,
- R 2 represents a monovalent hydrocarbon-based (hydrocarbyl) group, - v ⁇ 2, x ⁇ 0, y ⁇ 2,
- R 3 is a monovalent unsaturated aliphatic hydrocarbon-based group containing from 2 to 12 carbon atoms
- - c ranges from 0 to 50, d ranges from 0 to 100, e ranges from 0 to 100, with the condition that the ratio of (d+e)/(c+d+e) is greater than 0.5,
- R 3 represents a monovalent unsaturated aliphatic hydrocarbon-based group containing from 2 to 12 carbon atoms
- - c' represents a value greater than 4
- d' and e represent a value which can range from 0 to 100
- R 4 represents a hydrogen atom, an acyl group, or a monovalent hydrocarbon-based group containing 1 to 8 carbon atoms, in which said organic silicone elastomer has from 2% to 25% of ethylene oxide units,
- the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain makes it possible to confer, on the composition, slippery properties on application and after penetration, in particular while reducing the greasy effect sensation. Furthermore, the crosslinked silicone polymer is used for its emulsifying properties.
- the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain is a silicone polymer crosslinked with a polyoxypropylene chain, preferably having from 4 to 50 and better still from 10 to 30 propylene oxide units, and comprising at least one pendant polyoxyethylene chain, preferably having from 4 to 20 ethylene oxide units.
- the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain represents, in terms of active material, approximately 0.01% to 10% by weight, preferably approximately 0.15% to 7% by weight, relative to the total weight of the composition.
- the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain represents, in terms of active material, approximately 0.18% to 5.4% by weight, preferably approximately 0.36% to 3.6% by weight, relative to the total weight of the composition.
- the active material is first of all mixed with a hydrophobic liquid carrier so as to obtain a silicone elastomer gel.
- the silicone elastomer gel can then be mixed with a solvent.
- said solvent is chosen from water and a hydrophilic solvent.
- the silicone elastomer gel is then mixed with a solvent in a ratio of 100 parts by weight of solvent for 1 part by weight of the elastomer gel, and up to a ratio of 600 parts by weight of solvent for 1 part by weight of the elastomer gel, respectively, in order to obtain a crosslinked silicone elastomer paste.
- the compound A is a branched or linear organohydrosiloxane of average formula: (R 1 3 SiO 0.5 ) v (R 2 2 SiO) x (R 2 HSiO) y in which:
- R 1 represents a hydrogen or R 2 ,
- R 2 represents a monovalent hydrocarbon-based group
- x ranges from 1 to 500, preferably x ranges from 1 to
- y ranges from 2 to 200, preferably y ranges from 2 to
- R 2 may be a substituted or unsubstituted, aliphatic or aromatic hydrocarbon- based radical.
- alkyl groups such as methyl, ethyl, propyl, pentyl, octyl, undecyl and octadecyl groups; and also cycloalkyl groups such as the cyclohexyl group.
- halogenated alkyl groups such as chloromethyi, 3- chloropropyl and 3,3,3-trifluoropropyl.
- hydrocarbon-based aromatic group By way of example of a hydrocarbon-based aromatic group, mention may be made of phenyl, tolyl, xylyl, benzyl, styryl and 2-phenylethyl groups.
- the organohydrosiloxane may comprise an additional siloxy unit, in particular of average formula:
- R 1 represents a hydrogen atom or R 2 ,
- R 2 represents a monovalent hydrocarbon-based group, and v ⁇ 2, w ⁇ 0, x ⁇ 0, y ⁇ 2, and z ⁇ 0.
- the organohydrosiloxane is chosen from the following groups: dimethyl, methylhydropolysiloxane of average formula (CH 3 )3SiO[(CH 3 )2SiO3x[(CH 3 )HSiO]ySi(CH 3 )3 in which x ⁇ 0, preferably x ranges from 1 to 500, preferably x ranges from 1 to 200, and y ⁇ 2, preferably y ranges from 2 to 200, preferably y ranges from 2 to 100.
- the compound B is a polyoxyalkylene of average formula:
- R 3 is a monovalent unsaturated aliphatic hydrocarbon-based group containing from 2 to 12 carbon atoms
- - c ranges from 0 to 50, preferably from 0 to 10, preferably less than 2,
- - d ranges from 0 to 100, preferably from 1 to 100, preferably from 5 to 50,
- - e ranges from 0 to 100, preferably from 0 to 50, preferably from 0 to 30,
- the compound B is preferably a polyoxyalkylene with, at each chain end (i.e. alpha and omega positions), an unsaturated aliphatic hydrogenated group comprising from 2 to 12 carbon atoms.
- the polyoxyalkylene may result from the polymerization of ethylene oxide, of propylene oxide, of butylene oxide, of 1,2-epoxyhexane, of 1,2- epoxyoctane, or of cyclic epoxides such as cyclohexene oxide or exo-2,3- epoxynorbomane.
- the polyoxyalkylene group may comprise oxyethylene units (C 2 H 4 O), oxypropylene units (C 3 H 6 O), oxybutylene units (C 4 H 8 O), or mixtures thereof.
- the polyoxyalkylene group may comprise a mole majority of oxypropylene and oxybutylene units.
- the unsaturated aliphatic hydrocarbon-based group may be an alkenyl or alkynyl group.
- alkynyl groups having the following structures: HC ⁇ C-, HC ⁇ CCH 2 -, HC ⁇ CCH(CH 3 )- , HC ⁇ CC(CH 3 ) 2 - , HC ⁇ CC(CH 3 )2CH 2 - .
- the polyoxyalkylene is chosen from:
- the compound C comprises any catalyst commonly used for hydrosilylation reactions.
- a catalyst based on a metal of the platinum group is used.
- metal of the platinum group is intended to mean ruthenium, rhodium, palladium, osmium, iridium and platinum, and complexes thereof.
- Catalysts based on a metal of the platinum group which can be used to prepare the silicone elastomer according to the invention are the platinum complexes prepared as described by Willing, U. S. Pat. No. 3,419,593, and Brown et al, U. S. Pat. No. 5,175,325, incorporated by way of reference.
- Catalysts based on a metal of the platinum group which can be used mention may be made of those in Lee et al., U. S. Pat. No. 3,989,668; Chang et al., U. S. Pat. No. 5,036,117; Ashby, U. S. Pat No. 3,159,601; Lamoreaux, U. S. Pat No.
- the catalyst based on a metal of the platinum group may be a metal of the platinum group, said metal being deposited on a carrier such as silica gel or powdered carbon, or a compound or complex of said metal.
- a carrier such as silica gel or powdered carbon
- Mention may be made, by way of examples, of: chloroplatinic acid, either in its hexahydrate form or in its anhydrous form, a catalyst containing platinum obtained by means of a method reacting chloroplatinic acid with an unsaturated aliphatic organosilicone, such as divinyltetramethyldisiloxane, or the alkene-platinum-silyl complexes as described in U.S. Patent Application No.
- the amount of catalyst required depends on the catalyst used.
- the catalyst must be present in sufficient amount to provide at least 2 parts per million (ppm), preferably from 4 to 200 ppm, of platinum relative to the weight of total solids of the silicone elastomer gel (all the non-solvent compounds).
- ppm parts per million
- the catalyst is present in sufficient amount to provide 4 to 150 ppm by weight of platinum.
- the silicone elastomer comprises non-crosslinked pendant polyoxyalkylene groups. These groups are formed on the silicone elastomer via a hydrosilylation reaction by addition of the second polyoxyalkylene compound D) of average formula:
- R 3 represents a monovalent unsaturated aliphatic hydrocarbon-based group containing from 2 to 12 carbon atoms
- - c' represents a value greater than 4
- d' and e represent a value which can range from 0 to 100
- R 4 represents a hydrogen atom, an acyl group, or a monovalent hydrocarbon-based group containing 1 to 8 carbon atoms.
- the unsaturated aliphatic hydrogenated group in D may be an alkyl or alkenyl group.
- alkynyl groups having the following structures: HC ⁇ C-, HC ⁇ CCH 2 -, HC ⁇ CCH(CH 3 )- , HC ⁇ CC(CH 3 ) 2 - , HC ⁇ CC(CH 3 ) 2 CH 2 - .
- polyoxyalkylenes that may be used as compound D
- the polyether may also be chosen from those described in US 6 987 157, incorporated by way of reference.
- the compound D may be added to the silicone elastomer either during its formation (i.e. simultaneous reaction of the compounds A), B), C) and D)), or in a first reaction (for example by reacting a part of the SiH groups of the compound A) with C) and D)), subsequently followed by reaction with B), or subsequently added to the formed silicone elastomer having SiH groups (for example, unreacted SiH units present on the silicone elastomer).
- the amounts of compounds A, B and D used in the hydrosilylation reaction can vary, as long as the mole amount of the total unsaturated aliphatic groups present in the reaction of the compounds B) and D) is such that the mole ratio of the SiH units of the compound A) to the aliphatic unsaturated groups of the compounds B) and D) ranges from 10/1 to 1/10. However, the mole ratio of the aliphatic unsaturated groups of the compounds B) and D) to the SiH units of the compound A) is greater than 1 so as to have complete consumption of the SiH groups.
- the amounts and structures of B) and D) used may also vary. However, the amounts used and the structures of B) and D) are such that the organic silicone elastomer has a content of ethylene oxide units ranging from 2% to 25% by weight, preferably from 3% to 20% by weight, preferably from 4% to 18% by weight
- the content of ethylene oxide units means the average amount of ethylene oxide ("EO", i.e. CH 2 CH 2 O-) units present in the structure of the organic silicone elastomer.
- the organic silicone elastomer is crosslinked with a polyoxypropylene chain and the organic silicone elastomer also comprises pendant polyoxyethylene chains.
- the compound B is a polyoxypropylene (having in particular from 4 to 50, preferably 10 to 30 propylene oxide units) having an al!yl group at its two ends.
- the compound B has the general formula R 3 O-[(C 3 H 6 O) ⁇ r]-R 3 > with R 3 as defined above, and d' greater than 0, preferably d' ranges from 4 to 50, preferably from 10 to 30.
- the compound D is a polyoxyethylene (having in particular from 4 to 20 ethylene oxide units) having an allyl group at one end
- a sufficient amount of compound B is used to obtain a silicone elastomer with a content of propylene oxide units ranging from 5% to 50% by weight
- the compound B has the general formula R 3 O-[(C 2 H 4 O) c' ]-R 4 with R 3 and R 4 as defined above, and c' greater than 4, preferably c' ranges from 4 to 50, preferably from 10 to 30.
- Sufficient amounts of compound D are used to obtain a silicone elastomer with an ethylene oxide content ranging from 2% to 25% by weight
- the order of addition of the compounds A), B), C) and D) can vary.
- the reaction for the synthesis of the silicone elastomer is carried out in 2 steps. Firstly, the compounds A), C) and D) react so as to form a polyoxyethylene organohydrosiloxane copolymer, then the polyoxyethylene organohydrosiloxane copolymer reacts with the compound B) and additional amounts of C).
- the organic silicone elastomers are in a liquid carrier.
- the liquid carrier is the solvent used for the hydrosilylation reaction so as to form the organic silicone elastomer.
- liquid carriers By way of examples of liquid carriers, mention may be made of organic liquids (oils and solvents), silicones and mixtures thereof.
- the liquid carrier is an organic liquid.
- the organic liquids include oils and solvents.
- the organic liquids are, for example, aromatic hydrocarbons, aliphatic hydrocarbons, alcohols having more than 6 carbon atoms, aldehydes, ketones, amines, esters, ethers, glycols, glycol ethers, alkyl halides and aromatic halides.
- the hydrocarbons may be, for example: isododecane, isohexadecane, isoparaffins such as Isopar L (C11-C13) or Isopar H (C11-C12), or hydrogenated polydecene.
- the ethers and esters may be, for example: isodecyl neopentanoate, neopentylglycol heptanoate, glycol distearate, dicaprylyl carbonate, diethylhexyl carbonate, propylene glycol n-butyl ether, ethyl 3-ethoxypropionate, propylene glycol methyl ether acetate, tridecyl neopentanoate, propylene glycol methyl ether acetate (PGMEA), propylene glycol methyl ether (PGME), octyldodecyl neopentanoate, diisobutyl adipate, diisopropyl adipate, propylene glycol dicaprylate / dicaprate, and octyl palmitate.
- Organic fluid carriers may be fatty substances, oils, fatty acids and fatty alcohols.
- the liquid carrier may also be an organopolysiloxane of low viscosity or a volatile methylsiloxane or a volatile ethylsiloxane or a volatile methylethylsiloxane having a viscosity at 25°C ranging from 1 to 1000 mm 2 /dry, such as hexamethylcyclotrisiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane, tetradecamethylhexasiloxane, hexadecamethylheptasiloxane, heptamethy1-3- ⁇ (trimethylsilyl)oxy) ⁇ trisiloxane, hexamethyI-3,3- bis
- the liquid carrier may be a (C 6 -C 20 ) alkyl methicone.
- (C 6 -C 20 ) alkyl methicone mention may be made of caprylyl methicone, cetearyl methicone, ethyl methicone, hexyl methicone, lauryl methicone, myristyl methicone and stearyl methicone, preferably caprylyl methicone.
- the content of organic silicone elastomer and of liquid carrier is such that the silicone elastomer gel comprises from 2% to 95% by weight, preferably from 5% to 95% by weight, preferably from 10% to 90% by weight of organic silicone elastomer, and from 5% to 98% by weight, preferably from 95% to 5% by weight, preferably from 90% to 10% by weight of liquid carrier, such that the sum of the contents of silicone elastomer and of liquid carrier, and of any other compound, is equal to 100%.
- the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain is a polyoxyethylenated dimethicone polymer, in particular with 12 ethylene oxide units, crosslinked with bis-allyl polypropylene glycol in particular 20 ethylene oxide units, in particular used in the form of a gel carried in caprylyl methicone.
- a polyoxyethylenated dimethicone polymer in particular with 12 ethylene oxide units, crosslinked with bis-allyl polypropylene glycol in particular 20 ethylene oxide units, in particular used in the form of a gel carried in caprylyl methicone.
- Such an elastomer gel is in particular sold under the name EL-7040 Hydro elastomer blend by the company Dow Corning, and it has the INCI name [Caprylyl Methicone (and) PEG-12 Dimethicone/PPG- 20 Crosspolymer].
- the content of silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain of approximately 0.18% to 5.4% by weight, relative to the total weight of the composition is obtained by using approximately 1% to 30% by weight, relative to the total weight of the composition, of a crosslinked silicone elastomer paste as defined above.
- a content of silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain of approximately 0.36% to 3.6% by weight, relative to the total weight of the composition is obtained by using approximately 2% to 20% by weight, relative to the total weight of the composition, of a crosslinked silicone elastomer paste as defined above.
- composition according to the invention contains at least one semi- crystalline polymer, preferably derived from acrylic or methacrylic acid.
- semi-crystalline polymer is intended to mean polymers comprising a crystallizable, pendant-chain or block portion in the backbone, and an amorphous portion in the backbone, and having a first-order reversible change of phase temperature, in particular melting point (solid-liquid transition).
- the crystallizable portion is a block of the polymer backbone
- this crystallizable block is of chemical nature different than that of the amorphous blocks
- the semi-crystalline polymer is, in this case, a block polymer, for example of the diblock, triblock or multiblock type, comprising at least one crystallizable block and at least one amorphous block.
- block 11 is generally intended to mean at least 5 identical repeating units. The crystallizable block(s) are then of different chemical nature from the amorphous bIock(s).
- the semi-crystalline polymer of the composition of the invention has an average molecular weight (Mn) greater than or equal to about 2000, preferably from about 2000 to 800000, preferably from about 3000 to 500000, preferably from about 4000 to 150000, and preferably from about 4000 to 99000.
- Mn average molecular weight
- the semi-crystalline polymers are advantageously soluble in the oily phase at least 1% by weight, at a temperature that is higher than their melting point.
- the blocks of the polymers are amorphous.
- the term “crystallizable chain or block” is intended to mean a chain or block which, if it were alone, would change from the amorphous state to the crystalline state reversibly, depending on whether one is above or below the melting point.
- a chain is a group of atoms, which are pendant or lateral relative to the polymer backbone.
- a block is a group of atoms belonging to the backbone, this group constituting one of the repeating units of the polymer.
- the "pendant crystallizable chain” may be a chain containing at least 6 carbon atoms.
- the polymer backbone of the semi-crystalline polymers is soluble in the oily phase.
- the semi-crystalline polymer used in the composition of the invention is generally introduced into the oily phase of the composition.
- the semi-crystalline polymers used in the composition of the invention have a melting point, Mp, below 70°C (25°C ⁇ Mp ⁇ 70°C), this temperature being at least equal to the temperature of the keratin material which must receive the composition according to the invention, in particular the skin.
- the melting point may be measured in particular by any known method and in particular with a differential scanning calorimeter (DSC).
- the crystallizable blocks or chains of the semi-crystalline polymers represent at least approximately 30% by weight and preferably at least approximately 40% by weight relative to the total weight of each polymer.
- the semi-crystalline polymers comprising crystallizable blocks used according to the invention are block or multiblock polymers. They may be obtained via polymerization of monomers containing double bonds which are reactive (or which are ethylenic) or via polycondensation. When the polymers of the invention are polymers containing crystallizable side chains, they are advantageously in random or statistical form.
- the semi-crystalline polymers of the invention may be of synthetic origin. Moreover, they do not comprise a polysaccharide backbone.
- the semi-crystalline polymers that may be used in the invention are in particular:
- block copolymers of polyolefins with controlled crystallization suitable for the present invention are in particular those of which the monomers are described in EP-A-0951 897.
- homopolymers or copolymers bearing at least one crystallizable side chain and homopolymers or copolymers bearing at least one crystallizable block in the backbone that are particularly suitable for implementing the invention are those described in particular in document US-A-5 156911-
- homopolymers or copolymers bearing at least one crystallizable side chain are preferably those described in document WO-A-01/19333.
- the crystallizable side chain(s) or block(s) are hydrophobic. a) Semi-crystalline polymers containing crystallizable side chains:
- these polymers are chosen in particular from homopolymers and copolymers resulting from the polymerization of at least one monomer containing crystallizable chain(s) that may be represented by the following formula:
- M representing an atom of the polymer backbone
- S representing a spacer
- C representing a crystallizable group
- the crystallizable chains "-S-C” may be aliphatic or aromatic, and optionally fluorinated or perfluorinated.
- S represents in particular a group (CH 2 )n or (CH 2 CH 2 O) n or (CH 2 O), which may be linear or branched or cyclic, with n being an integer ranging from 0 to 22.
- n is an integer ranging from 0 to 22.
- S is a linear group.
- “S” and “C” are different
- crystallizable chains "-S-C” are hydrocarbon-based aliphatic chains, they comprise hydrocarbon-based alkyl chains containing at least 11 carbon atoms and at most 40 carbon atoms and preferably at most 24 carbon atoms. They are in particular aliphatic chains or alkyl chains containing at least 12 carbon atoms, and they are preferably C 14 -C 24 alkyl chains. When they are fluoroalkyl or perfluoroalkyl chains, they contain at least six fluorinated carbon atoms and in particular at least 11 carbon atoms, at least six of which carbon atoms are fluorinated.
- the invention relates to a composition for which the semi-crystalline polymer is chosen from a group comprising homopolymers and copolymers resulting from the polymerization of at least one monomer containing crystallizable chain(s), said chain being chosen from alkyl chains comprising at least 11 carbon atoms and at most 40 carbon atoms.
- semi-crystalline polymers or copolymers containing crystallizable chain(s) mention may be made of those resulting from the polymerization of one or more of the following monomers: saturated alkyl (meth)acrylates with the alkyl group being C 14 -C 24 , perfluoroalkyl (meth)acrylates with a C 11 -C 15 perfluoroalkyl group, N-alkyl(meth)acrylamides with the alkyl group being C 14 to C 24 with or without a fluorine atom, vinyl esters containing alkyl or perfluoro(alkyl) chains with the alkyl group being C 14 to C 24 (with at least 6 fluorine atoms per perfluoroalkyl chain), vinyl ethers containing alkyl or perfluoro(alkyl) chains with the alkyl group being Ct4 to C 24 and at least 6 fluorine atoms per perfluoroalkyl chain, C 14 to C 24 alpha-olefins such
- the hydrocarbon-based and/or fluorinated crystallizable chains as defined above are borne by a monomer that may be a diacicl, a diol, a diamine or a diisocyanate.
- the polymers that are the subject of the invention when they are copolymers, they additionally contain from 0 to 50% of groups Y resulting from the copolymerization of a monomer containing a crystallizable chain with Y which is a polar or non-polar monomer or a mixture of the two:
- Y when Y is a polar monomer, it is either a monomer bearing polyoxyalkylenated groups (in particular oxyethylenated and/or oxypropylenated groups), a hydroxyalkyl (meth)acrylate, for instance hydroxyethyl acrylate, (meth)acrylamide, an N-alkyl(meth)acrylamide, an N,N-dialkyl(meth)acrylamide such as, for example, N,N- cliisopropylacrylamide or N-vinylpyrrolidone (NVP), N-vinylcaprolactam, a monomer bearing at least one carboxylic acid group, for instance (meth)acrylic acid, crotonic acid, itaconic acid, maleic acid or fumaric acid, or bearing a carboxylic acid anhydride group, for instance maleic anhydride, the alkyl groups denoting a saturated group which is in particular C 8 to C 24 , and better still C 14 to C 24
- Y when Y is a non-polar monomer, it may be an ester of the linear, branched or cyclic alkyl (meth)acrylate type, a vinyl ester, an alkyl vinyl ether, an alpha-olefin, styrene or styrene substituted with a C 1 to C 10 alkyl group, for instance a-methylstyrene, the alkyl groups denoting a saturated group which is in particular Cg to C 24 , and better still C 14 to C 24 .
- alkyl is intended to mean a saturated group which is in particular C 8 to C 24 , unless expressly mentioned, and better still C 14 to C 24 .
- the polymers mat when the polymers mat are subjects of the invention are copolymers, they additionally contain from 0 to 50% of groups Z resulting from the copolymerization of a monomer containing a crystallizable chain with Z which is a polar monomer or a mixture of polar monomers.
- Z has the same definition as the "polar Y" defined above.
- the semi-crystalline polymers containing a crystallizable side chain are alkyl (meth)acrylate or alkyl(meth)acrylamide homopolymers with an alkyl group as defined above, and in particular of C 14 -C 24 , copolymers of these monomers with a hydrophilic monomer preferably of different nature from (meth)acrylic acid, for instance N-vinylpyrrolidone or hydroxyethyl (meth)acrylate, and mixtures thereof.
- These polymers are in particular block copolymers consisting of at least 2 blocks of different chemical nature, one of which is crystalHzable.
- block polymers defined in patent US-A-5 156 911 are particularly suitable.
- block copolymers of olefin or of cycloolefin containing a crystalHzable chain for instance those resulting from the block polymerization of:
- cyclobutene cyclohexene, cyclooctene, norbornene (i.e. bicyclo(2,2,1)-2- heptene), 5-methylnorbornene, 5-ethylnorbornene, 5,6-dimelhylnorbornene, 5,5,6- trimethylnorbomene, 5-ethylidenenorbornene, 5-phenylnorbornene, 5-benzylnorbornene, 5-vinylnorbornene, 1,4,5,8-dimethano-1,2,3,4,4a,5,8a-octahydronaphthalene, dicyclopentadiene, or mixtures thereof,
- the polymers resulting from the block copolymerization of at least two Ci- C 16 , preferably C 2 -C 12 and preferably C 4 -C 12 a-olefins such as those mentioned above and in particular block bipolymers of ethylene and of 1 -octene may also be used.
- the copolymers of interest may also be copolymers containing at least one crystalHzable block, the rest of the copolymer being amorphous (at ambient temperature). These copolymers may also contain two crystallizable blocks of different chemical nature.
- the preferred copolymers are those that simultaneously contain at ambient temperature a crystallizable block and an amorphous block that are both hydrophobic and lipophilic, sequentially distributed; mention may be made, for example, of polymers containing one of the crystallizable blocks and one of the amorphous blocks below: - block that is crystallizable by nature: a) of polyester type, for instance poly(alkylene terephthalate), b) of polyolefin type, for instance polyethylenes or polypropylenes;
- amorphous and lipophilic block for instance amorphous polyolefins or copoly(olefin)s such as poly(isobutylene), hydrogenated polybutadiene or hydrogenated poly(isoprene).
- poly( ⁇ -caprolactone)-b-poly(butadiene) block copolymers preferably used hydrogenated, such as those described by Nojima (Macromolecules, vol. (32), p. 3727-
- the semi-crystalline polymers of the composition of the invention may or may not be partially crosslinked, provided mat the degree of crosslinking is not detrimental to their dissolution or dispersion in the oily phase, by heating above their melting point It may then be a case of chemical crosslinking, by reaction with a multifunctional monomer during the polymerization. It may also be a case of physical crosslinking, which may then be due either to the establishment of bonds of hydrogen or dipolar type between groups borne by the polymer, for instance dipolar interactions between carboxylate ionomers, these interactions being in small amount and borne by the polymer backbone; or to a phase separation between the crystallizable blocks and the amorphous blocks, borne by the polymer.
- the semi-crystalline polymers of the composition according to the invention are not crosslinked.
- the polymer is chosen from copolymers resulting from the polymerization of at least one monomer containing a crystallizable chain chosen from saturated C 14 to C 24 alkyl (meth)acrylates, C 11 to C 15 perfluoroalkyl (meth)acrylates, Cu to C 24 N-aIkyl(meth)acrylamides with or without a fluorine atom, vinyl esters containing C 14 to C 24 alkyl or perfluoroalkyl chains, vinyl ethers containing C 14 to C 24 alkyl or perfluoroalkyl chains, C 14 to C 24 alpha-olefins, para-alkylstyrenes with an alkyl group containing from 12 to 24 carbon atoms, with at least one optionally fluorinated C 1 to C 10 monocarboxylic acid ester or amide, which may be represented by the following formula:
- R 1 is H or CH 3
- R represents an optionally fluorinated C 1 -C 10 alkyl group
- X represents O, NH or NR 2 in which R 2 represents an optionally fluorinated C 1 - C 10 alkyl group.
- the polymer is derived from a monomer containing a crystallizable chain chosen from saturated C 14 to C 22 alkyl (meth)acrylates and even more particularly poly(stearyl acrylate)s or poly(behenyl acrylate)s.
- the semi-crystalline polymer is chosen from homopolymers obtained by polymerization of a monomer chosen from C 14 - C 24 alkyl acrylates and C 14 -C 24 alkyl methacrylates and from copolymers obtained by copolymerization of a monomer chosen from C 14 -C 24 alkyl acrylates and C 14 -C 24 alkyl methacrylates, with a hydrophilic monomer.
- structuring semi-crystalline polymers that may be used in the composition according to the invention, mention may be made of polymers having the INCI name Poly C 10 -C 30 alkyl acrylate, for instance the Intelimer products from the company Air Products, for instance the product Intelimer IPA 13-1, which is a polystearyl acrylate, or the product Intelimer IPA 13-6, which is a behenyl polymer.
- the semi-crystalline polymer is a polymer having the INCI name: Poly C 10 -C 30 alkyl acrylate.
- the Inteliraer semi-crystalline polymer IPA 13-1 NG is known for its SPF booster effects, but it is barely or not at all compatible with the conventional silicone emulsifiers and, more generally, with conventional silicone ingredients.
- the semi-crystalline polymers may in particular be those described in Examples 3, 4, 5, 7, 9 and 13 of patent US-A-5 156 911 containing a -COOH group, resulting from the copolymerization of acrylic acid and of C 5 to C 16 alkyl (meth)acrylate and more particularly from the copolymerization:
- polymer of structure "O" from National Starch, such as that described in document US-A-5 736 125, with a melting point of 44°C, and also semi-crystalline polymers with crystallizable pendant chains comprising fluoro groups, as described in Examples 1, 4, 6, 7 and 8 of document WO-A-01/19333.
- the semi-crystalline polymers do not comprise any carboxylic groups.
- the semi-crystalline polymer(s) may represent, within the composition, approximately 0.05% to 10% by weight, preferably from 0.1% to 5% by weight and preferably from 0.2% to 3% by weight, relative to the total weight of the composition.
- the composition according to the invention also comprises at least one UV-screening agent.
- the inventors have noticed that the presence of at least one crosslinked silicone polymer and at least one semi-crystalline polymer, as described in the present invention, stabilizes an emulsion which comprises at least one UV-screening agent.
- any UV-screening agent known from the prior art is capable of being able to be formulated in the composition according to the present invention.
- PABA para-amino benzoic acid
- Ethylhexyl Dimethyl PABA in particular commercially available under the name Escalol 507 from the company ISP,
- Butyl Methoxydibenzoylmethane in particular commercially available under the name Parsol 1789 from Hofrmann-LaRoche,
- Ethylhexyl Salicylate in particular commercially available under the name Neo Heliopan OS from Haarmann and Reimer,
- Dipropylene Glycol Salicylate in particular commercially available under the name Dipsal from Scher
- TEA Salicylate in particular commercially available under the name Neo Heliopan TS from Haarmann and Reimer
- Ethylhexyl Methoxycinnamate in particular commercially available under the name Parsol MXC from the company Hoffmann-LaRoche,
- Neo Heliopan E 1000 from Haarmann and Reimer
- Octocrylene in particular commercially available under the name Uvinul N539 from BASF,
- Etocrylene in particular commercially available under the name Uvinul N35 from BASF,
- Benzophenone-1 in particular commercially available under the name Uvinul 400 from BASF,
- Benzophenone-2 in particular commercially available under the name Uvinul D50 from BASF,
- Benzophenone-3 or Oxybenzone in particular commercially available under the name Uvinul M40 from BASF,
- Benzophenone-6 in particular commercially available under the name Helisorb 11 from Norquay,
- Ethylhexyl triazone for example the product sold under the name Uvinul® T 150 by the company BASF, - Drometrizole trisiloxane, and in particular the product sold under the name Silatrizole® by the company Rhodia,
- composition in the form of a oil-in- water or water-in-oil emulsion may also contain at least one adjuvant chosen from the adjuvants which are customary in the cosmetics field.
- adjuvants are, for example, active ingredients, preservatives, antioxidants, complexing agents, thickeners, gelling agents, film-forming agents, surfactants, co-surfactants, moisturizing agents, solvents, fragrances, fillers, bactericides, fungicides, parasiticides, odour absorbers, pH regulators, anti-inflammatory agents, colorants (dyes and pigments), and also lipid vesicles.
- pigments 1 * should be understood as meaning white or coloured, mineral or organic particles that are insoluble in an aqueous solution, which are intended to colour and/or opacify the composition containing them.
- mineral pigments that may be used in the invention, mention may be made of titanium oxide, titanium dioxide, zirconium oxide, zirconium dioxide, cerium oxide or cerium dioxide and also zinc oxide, iron oxide or chromium oxide, ferric blue, manganese violet, ultramarine blue and chromium hydrate, and mixtures thereof.
- a pigment is sold, for example, under the reference Coverleaf NS or JS by the company Chemicals and Catalysts, and has a contrast ratio in the region of 30.
- pigments having a structure may be, for example, of silica microsphere type containing iron oxide.
- An example of a pigment having this structure is the product sold by the company Miyoshi under the reference PC Ball PC-LL- 100 P, this pigment consisting of silica microspheres containing yellow iron oxide.
- the pigments in accordance with the invention are iron oxides and/or titanium dioxides.
- these various adjuvants are those conventionally used in the field under consideration, and for example from 0.01% to 20% of the total weight of the composition.
- These adjuvants depending on their nature, can be introduced into the oily phase, into the aqueous phase and/or into lipid vesicles.
- compositions of the invention can be used in any cosmetic or dermatological application, for example in the cosmetics industry for caring for keratin materials, which includes any cosmetic application for caring for the skin, the hair, the scalp, the eyelashes, the eyebrows, the nails or the mucous membranes, for instance the lips.
- compositions according to the invention can be part of the production of protective, treatment or care products for the face, for the hands or for the body, as products for cleansing the skin, in particular of the face or of the body, as makeup products, for example foundations, or as hair products.
- the cosmetic compositions according to the invention have applications in a large number of cosmetic treatments for keratin materials, and more especially the skin, in particular for obtaining a feeling of softness of the skin and a silky effect.
- the composition of the invention is particularly suitable for treating skin showing imperfections and also dehydrated, rough or sensitive skin.
- a subject of the present invention is the cosmetic use of a composition as defined above, for caring for the skin, in particular dehydrated skin or skin comprising imperfections.
- a subject of the present invention is also the cosmetic use of a composition as defined above, for caring for the hair, in particular for conferring thereon a silky appearance.
- a composition according to the invention may be in various galenical forms conventionally used for topical applications and in particular in the form of dispersions of the serum type, emulsions of liquid or semi-liquid consistency of the milk type, obtained by dispersing an oily phase in an aqueous phase (O/W) or vice versa (W/O), or suspensions or emulsions of soft, semi-solid or solid consistency of the cream or gel type, or alternatively multiple emulsions (W/O/W or O/W/O), microemulsions, vesicular dispersions of ionic and/or nonionic type.
- These compositions are prepared according to the usual methods.
- compositions used according to the invention may be more or less fluid and may have the appearance of a gel, of a white or coloured cream, an ointment, a milk, a serum, a paste or a foam.
- the composition according to the invention is in the form of a water-in-oil emulsion comprising a continuous oily phase and an aqueous phase dispersed in said oily phase, or in the form of an oil-in-water emulsion comprising a continuous aqueous phase and an oily phase dispersed in said aqueous phase.
- a subject of the present invention is also a cosmetic method for attenuating the visible or tactile irregularities of the surface of the skin, comprising a topical administration of a composition according to the invention to the skin and/or the lips.
- the good penetration and the feeling of softness of the skin which are obtained after application of a composition according to the invention, reinforce the consumer's sensation of skin which has a smooth and uniform appearance.
- a subject of the present invention is also a cosmetic method for improving the appearance of the hair and/or the nails, comprising a topical administration of a composition according to the invention to the hair and/or the nails.
- the topical application of a composition makes it possible to reinforce the silky appearance of the hair and thus reduces the rough, coarse, brittle appearance.
- the topical administration can be carried out at a rate of at least once a day, of at least once every 2 days, of once every 3 days, or of once a week.
- the term "at least once a day” encompasses twice a day, 3 times a day, 4 times a day.
- compositions according to the invention The aqueous phase is prepared in a Rayneri mixer, by dissolving hydrophilic adjuvant(s) and or water-miscible solvents) in water (at the required temperature), and then a hydrophilic gelling agent is added with stirring at a temperature of approximately 70°C until the gel is homogeneous. The fatty phase is then homogenized, at a temperature suitable for obtaining a homogeneous liquid phase.
- an emulsion is conventionally produced by adding the aqueous phase to the oily phase with stirring in a Rayneri mixer. The emulsion is then cooled with stirring until a homogeneous smooth cream is obtained.
- the cosmetic properties were evaluated according to the following protocol.
- the cosmetic properties on application are evaluated, monadically, by a panel of experts trained in the description of care products.
- the sensory evaluation of the care products by this panel is performed as follows: the products are packaged in opaque jars or pump- dispenser bottles depending on the viscosity of the products. Within the same session, the samples are presented in random order to each panellist.
- the parameter is evaluated on a 5-level scale: no, little, medium, quite, very. A score was assigned to each level: no (0), little (1), medium (2), quite (3) and very (4). Subsequently, the scores assigned by each of the 15 experts are added so as to obtain an overall score.
- a ratio between the score obtained for the compositions according to the invention and the score obtained for the comparative compositions was calculated. A ratio greater than 1.25 was considered to be statistically significant for the parameter under consideration.
- Example 1 illustrates the evaluation of the stability properties of an emulsion according to the invention in comparison with an emulsion of which the formulation is adapted from document FR 2 912 651.
- Table 1 formulations of water-in-oil emulsions 1 and 2 (as % by weight relative to the total weight of the composition)
- KSG-210 from Shin Etsu, (25% of active material in dmiethicone); EL-7040 from Dow Corning (HSOEB, 18% of active material in CAPRYLYL METHICONE); 3 Sunscreens; 4 INTELIMER IPA 13-1; 5 The content is represented as % by weight of raw material relative to the total weight of the composition, which corresponds to a weight of active material of 3.24% by weight relative to the total weight of the composition; 6 Luvigel EM from BASF.
- the screening composition of the invention in which the crosslinked silicone polymer (PEG-12 Dimethicone/PPG-20 Crosspolymer) is used as an emulsifying elastomer, is more stable compared with the screening composition of the comparative example in which KSG210 is used as an emulsifying elastomer.
- the crosslinked silicone polymer PEG-12 Dimethicone/PPG-20 Crosspolymer
- Table 2 formulations of water-in-oil emulsions 3.4 and 5 (as % by weight relative to the total weight of the composition)
- the screening compositions according to the invention in which the crosslinked silicone polymer of HSOEB type (PEG- 12 Dimethicone/PPG-20 Crosspolymer) is used as an emulsifying elastomer and comprising a semi-crystalline polymer (Poly C 10 -C 30 Alkyl acrylate), are more stable than the composition of the comparative example not containing semi-crystalline polymer (Poly C 10 -C 30 Alkyl acrylate).
- the use of the semi-crystalline polymer (Intelimer IPA 13-1 NG) in combination with the crosslinked silicone polymer (PEG-12 Dimethicone/PPG-20 Crosspolymer), i.e. emulsions 4 and 5, makes it possible to significantly increase the SPF performance of the product compared with a formulation without semi-crystalline polymer (emulsion 3), without degrading the sensory effect.
- emulsion 3 a formulation without semi-crystalline polymer
- the screening emulsions according to the invention are also very fresh on application and very nourishing while at the same time retaining the qualities of softness, both on application and after application.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
The invention relates to a composition in the form of an emulsion, comprising, in a physiologically acceptable medium, at least: (i) one aqueous phase, (ii) one oily phase, (iii) one silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain, and (iv) one semi-crystalline polymer.
Description
"EMULSIONS STABILIZED WITH A CROSSLINKED SILICONE POLYMER AND A SEMI-CRYSTALLINE POLYMER" FIELD OF THE INVENTION
The invention relates to a composition in the form of an oil-in-water or a water-in-oil emulsion type.
It in particular relates to a cosmetic composition in the form of an oil-in-water or a water-in-oil emulsion type. Said cosmetic composition is in particular intended to be applied to keratin materials, in particular the skin and the lips, the hair and the nails.
More particularly, the invention relates to a cosmetic composition which is in the form of an emulsion, comprising at least one silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain and one semi-crystalline polymer.
TECHNICAL BACKGROUND
In the cosmetics field, and more particularly in the skincare, makeup and photoprotection field, emulsions containing at least one silicone elastomer are very advantageous for their application properties (particularly the slippery effect) and their very characteristic sensory effect (in particular, the provision of softness and the silky effect).
The stability of these emulsions is fragile and easily deteriorates when active molecules or ingredients such as UV -screening agents are added. To stabilize these emulsions, it has been proposed to use high contents of emulsifiers in order to increase the robustness of the architecture, which results in compromising the sensoriality and sometimes the innocuousness and the comfort on the skin of these products.
For example, document FR 2912 651 describes a composition in the form of a water-in-oil (W/O) emulsion containing at least one emulsifying silicone elastomer and at least one semi-crystalline polymer, providing a freshness effect during application and a very effective skin nutrition. However, these compositions exhibit medium stability in the presence of organic oils or of sunscreens. Furthermore, the application qualities of these
emulsions could be improved. Finally, the formulation perimeter is restricted, since these emulsions are limited to only water-in-oil emulsions.
Moreover, these silicone emulsions are not persistent and do not always provide good wear of the effects during the day. As it happens, the wear qualities are essential for ensuring the effectiveness of the active molecules, and maintaining moisturization, comfort, emollience and photoprotective properties, when the emulsion contains screening agents.
There is therefore a need to provide emulsions, and in particular water-in-oil emulsions, which have good stability. Advantageously, the emulsions according to the invention exhibit uniform application qualities and good comfort, and persistent properties over time, and exhibit good sensory attractiveness.
The term "stable" is intended to mean stable for at least one month, preferably at least 2 months, at 45°C.
SUMMARY OF THE INVENTION
According to a first aspect, the invention relates to a composition in the form of an emulsion comprising at least:
(i) one aqueous phase,
(ii) one oily phase,
(iii) one silicone polymer crosslinked with at least one poiyoxyalkylene chain and comprising at least one pendant poiyoxyalkylene chain, and
(iv) one semi-crystalline polymer.
In certain embodiments, said composition is a cosmetic composition. Said cosmetic composition is in particular suitable for topical application. The composition may be intended to be applied to keratin materials, in particular the skin and the lips, the hair and the nails.
According to another aspect, the invention relates to a cosmetic use of a composition according to the invention, for caring for keratin materials, preferably the skin, the lips, the hair and the nails.
According to another aspect, the invention relates to a method for the cosmetic treatment of keratin materials, comprising a topical admimstration of a composition according to the invention.
According to another aspect, the invention relates to a method for preparing a composition comprising at least:
(i) one aqueous phase,
(ii) one oily phase,
(iii) one silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain, and
(iv) one semi-crystalline polymer.
DETAILED DESCRIPTION OF THE INVENTION
Surprisingly, the inventors have developed emulsions based on at least one specific crosslinked silicone polymer, as emulsifier, and on at least one semi-crystalline polymer, which make it possible to obtain, after application, a feeling of softness, a good penetration quality, an absence of sensation of a residual oily or greasy effect, good stability and therefore good comfort immediately and over time. Notably, the effects observed are obtained both with water-in-oil (W/O) emulsions and with oil -in- water (O/W) emulsions. Finally, in the presence of UV-screening agents, the compositions according to me invention make it possible to increase the UV protection index.
1/ Composition
Physiologically acceptable medium
Since the compositions according to the invention are intended for topical application to the skin or skin appendages, they contain a physiologically acceptable medium. The term "physiologically acceptable medium'' is intended to mean a medium compatible with the skin, the lips, the mucous membranes, the nails, the scalp and/or the hair. In other words, a composition according to the invention must not contain compounds known to be toxic to human beings or animals.
Aqueous phase
In the context of the present invention, the aqueous phase comprises water and optionally at least one organic solvent which is water-miscible at ambient temperature (25°C) and/or at least one hydrophilic adjuvant The term "adjuvant" is intended to mean an active agent or additive, known in the prior art to have a physical, chemical and/or
biological property of interest in the context of skincare, dermatology, cosmetics and/or makeup.
As water-miscible organic solvent, mention may be made, in a non-limiting way, of in particular monoalcohols comprising from 2 to 8, preferably from 2 to 6 carbon atoms, such as ethanol, propanol, isopropanol, butanol, isobutanol, pentanol, hexanol, polyols having in particular from 2 to 20 carbon atoms, for instance glycerol, arabitol, adonitol, dulcitol, erythritol, pentylene glycol, propylene glycol, butylene glycol, isoprene glycol, hexylene glycol, (Methylene glycol, dipropylene glycol, polyglycerols with 2 to 6 glycerolated units, such as diglycerol, sorbitol; sugars such as glucose, fructose, maltose, lactose, sucrose, saccharose, xylose or trehalose; and mixtures thereof.
The composition may also contain thickening hydrophilic polymers such as homopolymers and copolymers of AMPS (for instance Hostacerin AMPS sold by the company Clariant), celluloses or acrylic polymers (such as carbopols, etc). Oilv phase
The oily phase consists of at least one oil or of any other fatty substance and lipophilic constituent which may be present in the composition of the invention, including the crosslinked silicone polymer. Any cosmetically acceptable oil may be used.
The term "oil" is intended to mean a fatty substance that is liquid at ambient temperature (25°C).
As oils that may be used in the composition of the invention, examples that may be mentioned include:
- hydrocarbon-based oils of animal origin, such as perhydrosqualene and squalane;
- hydrocarbon-based oils of vegetable origin, such as liquid triglycerides of C4- C10 fatty acids, for instance heptanoic or octanoic acid triglycerides, caprylic/capric acid triglycerides, for instance those sold by the company Stearineries Dubois or those available under the trade names Miglyol 810, Miglyol 812 and Miglyol 818 from the company Dynamit Nobel, or else, for example, sunflower oil, corn oil, soya bean oil, marrow oil, grape seed oil, sesame oil, hazelnut oil, apricot oil, macadamia oil, castor oil, avocado oil, jojoba oil and shea butter oil;
- synthetic esters and ethers, in particular of fatty acids, for instance the oils of formulae R1COOR2 and R1OR2 in which Ri represents a C8 to C29 fatty acid residue and R2 represents a C3 to C30 branched or unbranched hydrocarbon-based chain, for instance purcellin oil, isononyl isononanoate, isopropyl myristate, 2-ethylhexyl palmitate, 2- octyldodecyl stearate, 2-octyldodecyl erucate, isostearyl isostearate, octanoates and decanoates of C8- C30 fatty alcohols; esters of hydroxylated acid and of C8-C30 fatty alcohol, for instance isostearyl lactate, octyl hydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate; polyol esters, for instance propylene glycol dioctanoate, neopentyl glycol diheptanoate and diethylene glycol diisononanoate; and pentaerythritol esters, for instance pentaerythrityl tetraisostearate (for instance Crodamol ΡTIS from Croda);
- linear or branched hydrocarbons of mineral or synthetic origin, such as volatile or non-volatile liquid paraffins, and derivatives thereof, petroleum jelly, polydecenes, and hydrogenated polyisobutene such as Parleam oil;
- silicone oils, for instance volatile or non-volatile polymethyisiloxanes
(PDMSs) containing a linear or cyclic silicone chain, which are liquid or pasty at ambient temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexasUoxane and cyclopentasiloxane; polydimethylsiloxanes (or dimethicones) comprising alkyl, alkoxy or phenyl groups, which are pendant or at the end of a silicone chain, these groups containing from 2 to 24 carbon atoms; phenylsilicones, for instance phenyl trimethicones, phenyl dimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl dimethicones, diphenylmethyldiphenyltrisiloxanes, 2-phenylethyl trimethylsiloxysilicates and polymethylphenylsiloxanes;
- fait y alcohols containing from 8 to 26 carbon atoms, for instance cetyl alcohol, stearyl alcohol and a mixture thereof (cetylstearyl alcohol);
- partially hydrocarbon-based and/or silicone-based fluoro oils, for instance those described in document JP-A-2-295 912;
- and mixtures thereof.
The term "hydrocarbon-based oil" above is intended to mean any oil mainly comprising carbon and hydrogen atoms, and optionally ester, ether, fluoro, carboxylic acid and/or alcohol groups.
In addition to the oils indicated above, the composition of the invention may contain other fatty substances in the oily phase, such as C8 to C30 fatty acids, for instance stearic acid; silicone resins such as trifluoromethyl(C1-C4 alkyl) dimethicone and trifluoropropyl dimethicone; silicone gums (dimethiconol), non-emulsifying silicone elastomers, for instance the products sold under the names KSG 6 and KSG 16 by the company Shin-Etsu, under the names Trefll, BY29 and EPSX by the company Dow Corning, or under the name Gransil by the company Grant Industries; waxes, for example mineral waxes, waxes of animal origin, for instance beeswax, waxes of plant origin, hydrogenated oils that are solid at 25°C, glycerides that are solid at 25°C, synthetic waxes and silicone waxes; and mixtures thereof.
Finally, the oily phase may contain one or more waxes chosen from those described above, and in particular a synthetic wax such as polymethylene wax or polyethylene wax, or alternatively one or more pasty fatty compounds such as petroleum jelly.
For the purposes of the present invention, the term "pasty compound'' is intended to mean a compound that is water-immiscible and that undergoes a reversible solid/liquid change of state and that comprises in the solid state an anisotropic crystal organization, and comprises, at a temperature of 23°C, a liquid fraction and a solid fraction.
According to one particular embodiment, the oily phase may also comprise one or more lipophilic adjuvant(s), such as, for example, one or more oily thickeners.
By way of thickener, mention may be made, for example, of organomodified clays, which are clays treated with compounds chosen in particular from quaternary amines and tertiary amines. Organomodified clays that may be mentioned include organomodified bentonites such as those which are commercially available under the name Bentone from the company Rheox, for instance those modified with distearyldimethylammonium chloride (Bentone 38 and Bentone 34), or the product modified with stearylbenzyldimethylammonium chloride (Bentone 27).
The oily-phase thickener may advantageously be chosen from C8- C30 fatty acid esters of glycerol, and in particular C8-C30 fatty acid triesters of glycerol, such as glyceryl tristearate (tristearine), such as the mixture of acetylated glycol stearate and of glyceryl tristearate, sold under the name Unitwix by the company United Guardian.
The oily-phase thickener may also be chosen from C8-C30 fatty acid esters of dextrin, such as, in particular, dextrin palmitate, in particular those sold under the name Rheopearl by the company Chiba Flour Milling.
The thickeners) may be present in an amount ranging, for example, from approximately 0.1% to 5% by weight, preferably approximately 0.1% to 3% by weight and preferably approximately 0.2% to 2% by weight, relative to the total weight of the composition.
In the context of the present invention, it is understood mat the term "approximately" means that the value to which it refers encompasses said value +/-10%. Thus, 5% represents a value included strictly between 4.5% and 5.5%.
Oil-in-water (O/W) emulsion
In the context of the present invention, when the composition is in the form of an oil-in-water emulsion, the aqueous phase may represent approximately 60% to 98% by weight, preferably approximately 65% to 95% by weight, preferably approximately 70% to 90% by weight and preferably approximately 70% to 85% by weight, relative to the total weight of the composition.
The hydrophilic adjuvant(s), for instance the polyols and the monoalcohols, may represent approximately 0% to 30% by weight, preferably approximately 0.1% to 30% by weight, and preferably approximately 1% to 20% by weight, relative to the total weight of the composition.
When the composition is in the form of an oil-in-water emulsion, the water may be present in a content ranging from 60% to 98% by weight, preferably from 65% to 95% by weight, preferably approximately 70% to 90% by weight and preferably approximately 70% to 85% by weight, relative to the total weight of the composition.
According to another aspect of the invention, the oily phase, within the composition in the form of an oil-in-water emulsion, represents a value less than or equal to approximately 35% by weight, preferably a value less than or equal to approximately 33% by weight, preferably a value less than or equal to approximately 32% by weight, relative to the total weight of the composition.
According to another aspect of the invention, the oily phase may represent approximately 2% to 35% by weight, preferably approximately 5% to 33% by weight,
preferably approximately 10% to 33% by weight and preferably approximately 15% to 30% by weight, relative to the total weight of the composition.
According to another particular embodiment, a composition in the form of an oil-in-water emulsion comprises an oil(s) content of less than or equal to approximately 35% by weight, preferably less than or equal to approximately 33% by weight and preferably less than or equal to 32% by weight, relative to the total weight of the composition.
Water-in-oil (W/O) emulsion
In the context of the present invention, when the composition is in the form of a water-in-oil W/O emulsion, the aqueous phase may represent approximately 30% to 95% by weight, preferably approximately 35% to 90% by weight and preferably approximately 40% to 85% by weight, relative to the total weight of the composition.
In one particular embodiment, the water preferably represents at least approximately 30% by weight, preferably at least approximately 40% by weight, preferably at least approximately 50% by weight, relative to the total weight of the composition. This amount may represent, for example, approximately 30% to 90% by weight, preferably approximately 40% to 80% by weight and preferably approximately 50% to 75% by weight, relative to the total weight of the composition.
According to one preferred embodiment, the oily phase represents approximately 0.5% to 50% by weight, relative to the total weight of the composition, preferably approximately 10% to 35% by weight, relative to the total weight of the composition. Crosslinked silicone polymer
In the context of the invention, a crosslinked silicone polymer is in particular described in PCT international application WO 2010/080755.
The crosslinked silicone polymer, in particular in the form of an organic silicone elastomer gel, contains an organic silicone elastomer and a hydrophobic liquid carrier.
The organic silicone elastomer may represent approximately 2% to 95% by weight, relative to the total weight of the elastomer gel, while the hydrophobic liquid
carrier may represent approximately 5% to 98% by weight, relative to the total weight of the elastomer gel.
Additional constituents, in addition to the organic silicone elastomer and the hydrophobic liquid carrier, may be added to the organic silicone elastomer gel; in this case, the amounts of all the constituents used must correspond exactly to 100% by weight.
According to one preferred embodiment, the silicone elastomer gel comprises: - 2% to 95% by weight, relative to the total weight of the silicone elastomer gel, of an organic silicone elastomer, obtained by reacting:
A) an organohydrogenosiloxane comprising siloxy units of average formula: (R1 3SiO0.5)v (R2 2SiO)x (R2HSiO)y
in which:
- R1 represents a hydrogen or R2,
- R2 represents a monovalent hydrocarbon-based (hydrocarbyl) group, - v≥2, x≥ 0, y≥ 2,
B) a first polyoxyalkylene having the average formula:
R3O-[(C2H4O)c(C3H6O)d(C4H8O)e]-R3
in which:
- R3 is a monovalent unsaturated aliphatic hydrocarbon-based group containing from 2 to 12 carbon atoms,
- c ranges from 0 to 50, d ranges from 0 to 100, e ranges from 0 to 100, with the condition that the ratio of (d+e)/(c+d+e) is greater than 0.5,
C) a hydrosilylation catalyst,
D) a second polyoxyalkylene having the average formula:
R3O[(C2H4O)c' (C3H6O)d' (C4H8O)e]-R4
in which:
- R3 represents a monovalent unsaturated aliphatic hydrocarbon-based group containing from 2 to 12 carbon atoms,
- c' represents a value greater than 4, d' and e represent a value which can range from 0 to 100,
- R4 represents a hydrogen atom, an acyl group, or a monovalent hydrocarbon-based group containing 1 to 8 carbon atoms,
in which said organic silicone elastomer has from 2% to 25% of ethylene oxide units,
- 5% to 98% by weight, relative to the total weight of the silicone elastomer gel, of a hydrophobic liquid carrier.
The silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain makes it possible to confer, on the composition, slippery properties on application and after penetration, in particular while reducing the greasy effect sensation. Furthermore, the crosslinked silicone polymer is used for its emulsifying properties.
According to one preferred embodiment, the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain is a silicone polymer crosslinked with a polyoxypropylene chain, preferably having from 4 to 50 and better still from 10 to 30 propylene oxide units, and comprising at least one pendant polyoxyethylene chain, preferably having from 4 to 20 ethylene oxide units.
According to one preferred embodiment, the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain represents, in terms of active material, approximately 0.01% to 10% by weight, preferably approximately 0.15% to 7% by weight, relative to the total weight of the composition. According to another preferred embodiment, the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain represents, in terms of active material, approximately 0.18% to 5.4% by weight, preferably approximately 0.36% to 3.6% by weight, relative to the total weight of the composition.
In practice, the active material is first of all mixed with a hydrophobic liquid carrier so as to obtain a silicone elastomer gel. Subsequently, the silicone elastomer gel can then be mixed with a solvent. In certain embodiments, said solvent is chosen from water and a hydrophilic solvent. In certain embodiments, the silicone elastomer gel is then mixed with a solvent in a ratio of 100 parts by weight of solvent for 1 part by weight of the elastomer gel, and up to a ratio of 600 parts by weight of solvent for 1 part by weight of the elastomer gel, respectively, in order to obtain a crosslinked silicone elastomer paste.
A. organohvdrosiloxane
The compound A is a branched or linear organohydrosiloxane of average formula: (R1 3SiO0.5)v (R2 2SiO)x(R2HSiO)y in which:
- R1 represents a hydrogen or R2,
- R2 represents a monovalent hydrocarbon-based group,
- v≥ 2,
- x≥ 0, preferably x ranges from 1 to 500, preferably x ranges from 1 to
200,
- y≥ 2, preferably y ranges from 2 to 200, preferably y ranges from 2 to
100.
R2 may be a substituted or unsubstituted, aliphatic or aromatic hydrocarbon- based radical.
As monovalent, unsubstituted aliphatic hydrocarbon-based radicals, mention may, for example, be made of alkyl groups, such as methyl, ethyl, propyl, pentyl, octyl, undecyl and octadecyl groups; and also cycloalkyl groups such as the cyclohexyl group.
As monovalent, substituted aliphatic hydrocarbon-based radicals, mention may, for example, be made of halogenated alkyl groups, such as chloromethyi, 3- chloropropyl and 3,3,3-trifluoropropyl.
By way of example of a hydrocarbon-based aromatic group, mention may be made of phenyl, tolyl, xylyl, benzyl, styryl and 2-phenylethyl groups.
According to one embodiment, the organohydrosiloxane may comprise an additional siloxy unit, in particular of average formula:
(R1 3SiO0.5)v (R2 2SiO)x(R2HSiO)y(R2SiO1.5)z,
(R1 3SiO0.5)v(R2 2SiO)x(R2HSiO)y(SiO2)w,
(R1 3SiO0.5)v (R2 2SiO)x(R2HSiO)y(SiO2)w(R2SiO1.5)z
or mixtures thereof,
in which R1 represents a hydrogen atom or R2,
R2 represents a monovalent hydrocarbon-based group, and v≥2, w≥ 0, x≥0, y≥ 2, and z≥0.
According to one embodiment, the organohydrosiloxane is chosen from the following groups: dimethyl, methylhydropolysiloxane of average formula (CH3)3SiO[(CH3)2SiO3x[(CH3)HSiO]ySi(CH3)3 in which x≥ 0, preferably x ranges from 1
to 500, preferably x ranges from 1 to 200, and y≥ 2, preferably y ranges from 2 to 200, preferably y ranges from 2 to 100.
B, first polvoxvalkvlene
The compound B is a polyoxyalkylene of average formula:
R3O-[(C2H4O)c(C3H6O)d(C4H8O)e]-R3
in which:
- R3 is a monovalent unsaturated aliphatic hydrocarbon-based group containing from 2 to 12 carbon atoms,
- c ranges from 0 to 50, preferably from 0 to 10, preferably less than 2,
- d ranges from 0 to 100, preferably from 1 to 100, preferably from 5 to 50,
- e ranges from 0 to 100, preferably from 0 to 50, preferably from 0 to 30,
with the condition that the ratio of (d+e)/(c+d+e) is greater than 0.5, preferably greater than 0.8, preferably greater than 0.95.
The compound B is preferably a polyoxyalkylene with, at each chain end (i.e. alpha and omega positions), an unsaturated aliphatic hydrogenated group comprising from 2 to 12 carbon atoms. The polyoxyalkylene may result from the polymerization of ethylene oxide, of propylene oxide, of butylene oxide, of 1,2-epoxyhexane, of 1,2- epoxyoctane, or of cyclic epoxides such as cyclohexene oxide or exo-2,3- epoxynorbomane.
The polyoxyalkylene group may comprise oxyethylene units (C2H4O), oxypropylene units (C3H6O), oxybutylene units (C4H8O), or mixtures thereof. For example, the polyoxyalkylene group may comprise a mole majority of oxypropylene and oxybutylene units.
The unsaturated aliphatic hydrocarbon-based group may be an alkenyl or alkynyl group.
By way of examples, mention may be made of the alkenyl groups having the following structures: H2C=CH-, H2C=CHCH2-, H2C=C(CH3)CH2- , H2C=CHCH2CH2-, H2C=CHCH2CH2CH2 -, and H2C=CHCH2CH2CH2CH2-, preferably H2C=CHCH2.
By way of examples, mention may be made of the alkynyl groups having the following structures: HC≡C-, HC≡CCH2-, HC≡CCH(CH3)- , HC≡CC(CH3)2- , HC≡CC(CH3)2CH2- .
According to one embodiment, the polyoxyalkylene is chosen from:
H2C=CHCH2O[C3H6O]dCH2CH=CH2
H2C=C(CH3)CH2O[C3H6O]dCH2C(CH3)=CH2
HC≡CCH2O[C3H6O]dCH2C≡CH, or
HC≡CC(CH3)2O[C3H6O]dC(CH3)2C≡CH
preferably H2C=CHCH2O[C3H6O]dCH2CH=CH2
with d being as defined above.
C. hvdrosilvlation catalyst
The compound C comprises any catalyst commonly used for hydrosilylation reactions.
According to one preferred embodiment, a catalyst based on a metal of the platinum group is used. The term "metal of the platinum group" is intended to mean ruthenium, rhodium, palladium, osmium, iridium and platinum, and complexes thereof.
Catalysts based on a metal of the platinum group which can be used to prepare the silicone elastomer according to the invention are the platinum complexes prepared as described by Willing, U. S. Pat. No. 3,419,593, and Brown et al, U. S. Pat. No. 5,175,325, incorporated by way of reference. As other examples of catalysts based on a metal of the platinum group which can be used, mention may be made of those in Lee et al., U. S. Pat. No. 3,989,668; Chang et al., U. S. Pat. No. 5,036,117; Ashby, U. S. Pat No. 3,159,601; Lamoreaux, U. S. Pat No. 3,220,972; Chalk et al., U. S. Pat. No. 3,29631; Modic, U. S. Pat. No. 3,516,946; Karstedt, U. S. Pat. No. 3,814,730; and Chandra et al., U.S. Pat No. 3,928,629 incorporated by way of reference.
The catalyst based on a metal of the platinum group may be a metal of the platinum group, said metal being deposited on a carrier such as silica gel or powdered carbon, or a compound or complex of said metal. Mention may be made, by way of examples, of: chloroplatinic acid, either in its hexahydrate form or in its anhydrous form, a catalyst containing platinum obtained by means of a method reacting chloroplatinic acid with an unsaturated aliphatic organosilicone, such as divinyltetramethyldisiloxane, or the
alkene-platinum-silyl complexes as described in U.S. Patent Application No. 10/017229, such as (COD)Pt(SiMeCl2)2, where COD is 1 ,5-cyclooctadiene and Me is methyl. These alkene-platinum-silyl complexes can be prepared, for example, by mixing 0.015 mol of (COD)PtCI2 with 0.045 mol of COD and 0.0612 mol of HMeSiCl2.
The amount of catalyst required depends on the catalyst used. The catalyst must be present in sufficient amount to provide at least 2 parts per million (ppm), preferably from 4 to 200 ppm, of platinum relative to the weight of total solids of the silicone elastomer gel (all the non-solvent compounds). For example, the catalyst is present in sufficient amount to provide 4 to 150 ppm by weight of platinum.
D. second polvoxvalkvlene
The silicone elastomer comprises non-crosslinked pendant polyoxyalkylene groups. These groups are formed on the silicone elastomer via a hydrosilylation reaction by addition of the second polyoxyalkylene compound D) of average formula:
R3O[(C2H4O)c' (C3H6O)d' (C4H8O)e]-R4
in which
- R3 represents a monovalent unsaturated aliphatic hydrocarbon-based group containing from 2 to 12 carbon atoms,
- c' represents a value greater than 4, d' and e represent a value which can range from 0 to 100,
- R4 represents a hydrogen atom, an acyl group, or a monovalent hydrocarbon-based group containing 1 to 8 carbon atoms.
The unsaturated aliphatic hydrogenated group in D may be an alkyl or alkenyl group.
By way of examples, mention may be made of the alkenyl groups having the following structures: H2C=CH-, H2C=CHCH2-, H2C=C(CH3)CH2- , H2C=CHCH2CH2-, H2C=CHCH2CH2CH2 -, and H2C=CHCH2CH2CH2CH2-.
By way of examples, mention may be made of the alkynyl groups having the following structures: HC≡C-, HC≡CCH2-, HC≡CCH(CH3)- , HC≡CC(CH3)2- , HC≡CC(CH3)2CH2- .
with c* and d' being as defined above.
The polyether may also be chosen from those described in US 6 987 157, incorporated by way of reference.
The compound D may be added to the silicone elastomer either during its formation (i.e. simultaneous reaction of the compounds A), B), C) and D)), or in a first reaction (for example by reacting a part of the SiH groups of the compound A) with C) and D)), subsequently followed by reaction with B), or subsequently added to the formed silicone elastomer having SiH groups (for example, unreacted SiH units present on the silicone elastomer).
The amounts of compounds A, B and D used in the hydrosilylation reaction can vary, as long as the mole amount of the total unsaturated aliphatic groups present in the reaction of the compounds B) and D) is such that the mole ratio of the SiH units of the compound A) to the aliphatic unsaturated groups of the compounds B) and D) ranges from
10/1 to 1/10. However, the mole ratio of the aliphatic unsaturated groups of the compounds B) and D) to the SiH units of the compound A) is greater than 1 so as to have complete consumption of the SiH groups.
The amounts and structures of B) and D) used may also vary. However, the amounts used and the structures of B) and D) are such that the organic silicone elastomer has a content of ethylene oxide units ranging from 2% to 25% by weight, preferably from 3% to 20% by weight, preferably from 4% to 18% by weight For the purposes of the present invention, the content of ethylene oxide units means the average amount of ethylene oxide ("EO", i.e. CH2CH2O-) units present in the structure of the organic silicone elastomer.
According to one embodiment, the organic silicone elastomer is crosslinked with a polyoxypropylene chain and the organic silicone elastomer also comprises pendant polyoxyethylene chains. According to this embodiment, the compound B is a polyoxypropylene (having in particular from 4 to 50, preferably 10 to 30 propylene oxide units) having an al!yl group at its two ends. Thus, according to this embodiment, the compound B has the general formula R3O-[(C3H6O)<r]-R3 > with R3 as defined above, and d' greater than 0, preferably d' ranges from 4 to 50, preferably from 10 to 30. According to this embodiment, the compound D is a polyoxyethylene (having in particular from 4 to 20 ethylene oxide units) having an allyl group at one end
According to one embodiment, a sufficient amount of compound B is used to obtain a silicone elastomer with a content of propylene oxide units ranging from 5% to 50% by weight According to this embodiment, the compound B has the general formula R3O-[(C2H4O)c']-R4 with R3 and R4 as defined above, and c' greater than 4, preferably c' ranges from 4 to 50, preferably from 10 to 30. Sufficient amounts of compound D are used to obtain a silicone elastomer with an ethylene oxide content ranging from 2% to 25% by weight
The order of addition of the compounds A), B), C) and D) can vary. However, according to one embodiment, the reaction for the synthesis of the silicone elastomer is carried out in 2 steps. Firstly, the compounds A), C) and D) react so as to form a polyoxyethylene organohydrosiloxane copolymer, then the polyoxyethylene
organohydrosiloxane copolymer reacts with the compound B) and additional amounts of C).
E. hydrophobic fluid carrier
The organic silicone elastomers are in a liquid carrier.
According to one embodiment, the liquid carrier is the solvent used for the hydrosilylation reaction so as to form the organic silicone elastomer.
By way of examples of liquid carriers, mention may be made of organic liquids (oils and solvents), silicones and mixtures thereof.
According to one embodiment, the liquid carrier is an organic liquid. The organic liquids include oils and solvents. The organic liquids are, for example, aromatic hydrocarbons, aliphatic hydrocarbons, alcohols having more than 6 carbon atoms, aldehydes, ketones, amines, esters, ethers, glycols, glycol ethers, alkyl halides and aromatic halides. The hydrocarbons may be, for example: isododecane, isohexadecane, isoparaffins such as Isopar L (C11-C13) or Isopar H (C11-C12), or hydrogenated polydecene. The ethers and esters may be, for example: isodecyl neopentanoate, neopentylglycol heptanoate, glycol distearate, dicaprylyl carbonate, diethylhexyl carbonate, propylene glycol n-butyl ether, ethyl 3-ethoxypropionate, propylene glycol methyl ether acetate, tridecyl neopentanoate, propylene glycol methyl ether acetate (PGMEA), propylene glycol methyl ether (PGME), octyldodecyl neopentanoate, diisobutyl adipate, diisopropyl adipate, propylene glycol dicaprylate / dicaprate, and octyl palmitate. Organic fluid carriers may be fatty substances, oils, fatty acids and fatty alcohols.
The liquid carrier may also be an organopolysiloxane of low viscosity or a volatile methylsiloxane or a volatile ethylsiloxane or a volatile methylethylsiloxane having a viscosity at 25°C ranging from 1 to 1000 mm2/dry, such as hexamethylcyclotrisiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane, tetradecamethylhexasiloxane, hexadecamethylheptasiloxane, heptamethy1-3-{(trimethylsilyl)oxy)}trisiloxane, hexamethyI-3,3- bis{(trimethylsilyl)oxy}trisiloxane, pentamemyl{(trimemylsilyl)oxy}cyclotrisiloxane and
also polydimethylsiloxanes, polyethylsiloxanes, polymethylethylsiloxanes, polymethylphenylsiloxanes, polydiphenylsiloxanes, and mixtures thereof.
The liquid carrier may be a (C6-C20) alkyl methicone. By way of examples of (C6-C20) alkyl methicone, mention may be made of caprylyl methicone, cetearyl methicone, ethyl methicone, hexyl methicone, lauryl methicone, myristyl methicone and stearyl methicone, preferably caprylyl methicone.
The content of organic silicone elastomer and of liquid carrier is such that the silicone elastomer gel comprises from 2% to 95% by weight, preferably from 5% to 95% by weight, preferably from 10% to 90% by weight of organic silicone elastomer, and from 5% to 98% by weight, preferably from 95% to 5% by weight, preferably from 90% to 10% by weight of liquid carrier, such that the sum of the contents of silicone elastomer and of liquid carrier, and of any other compound, is equal to 100%.
According to one preferred embodiment, the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain is a polyoxyethylenated dimethicone polymer, in particular with 12 ethylene oxide units, crosslinked with bis-allyl polypropylene glycol in particular 20 ethylene oxide units, in particular used in the form of a gel carried in caprylyl methicone. Such an elastomer gel is in particular sold under the name EL-7040 Hydro elastomer blend by the company Dow Corning, and it has the INCI name [Caprylyl Methicone (and) PEG-12 Dimethicone/PPG- 20 Crosspolymer].
Thus, in this particular embodiment, the content of silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain of approximately 0.18% to 5.4% by weight, relative to the total weight of the composition, is obtained by using approximately 1% to 30% by weight, relative to the total weight of the composition, of a crosslinked silicone elastomer paste as defined above.
Likewise, a content of silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain of approximately 0.36% to 3.6% by weight, relative to the total weight of the composition, is obtained by using approximately 2% to 20% by weight, relative to the total weight of the composition, of a crosslinked silicone elastomer paste as defined above.
Semi-crvstalline polymer
The composition according to the invention contains at least one semi- crystalline polymer, preferably derived from acrylic or methacrylic acid. For the purposes of the invention, the term "semi-crystalline polymer" is intended to mean polymers comprising a crystallizable, pendant-chain or block portion in the backbone, and an amorphous portion in the backbone, and having a first-order reversible change of phase temperature, in particular melting point (solid-liquid transition). When the crystallizable portion is a block of the polymer backbone, this crystallizable block is of chemical nature different than that of the amorphous blocks; the semi-crystalline polymer is, in this case, a block polymer, for example of the diblock, triblock or multiblock type, comprising at least one crystallizable block and at least one amorphous block. The term "block11 is generally intended to mean at least 5 identical repeating units. The crystallizable block(s) are then of different chemical nature from the amorphous bIock(s).
Advantageously, the semi-crystalline polymer of the composition of the invention has an average molecular weight (Mn) greater than or equal to about 2000, preferably from about 2000 to 800000, preferably from about 3000 to 500000, preferably from about 4000 to 150000, and preferably from about 4000 to 99000.
In the composition according to the invention, the semi-crystalline polymers are advantageously soluble in the oily phase at least 1% by weight, at a temperature that is higher than their melting point. Besides the crystallizable chains or blocks, the blocks of the polymers are amorphous. For the purposes of the invention, the term "crystallizable chain or block" is intended to mean a chain or block which, if it were alone, would change from the amorphous state to the crystalline state reversibly, depending on whether one is above or below the melting point. For the purposes of the invention, a chain is a group of atoms, which are pendant or lateral relative to the polymer backbone. A block is a group of atoms belonging to the backbone, this group constituting one of the repeating units of the polymer. Advantageously, the "pendant crystallizable chain" may be a chain containing at least 6 carbon atoms.
Preferably, the polymer backbone of the semi-crystalline polymers is soluble in the oily phase. Thus, the semi-crystalline polymer used in the composition of the invention is generally introduced into the oily phase of the composition.
Preferably, the semi-crystalline polymers used in the composition of the invention have a melting point, Mp, below 70°C (25°C≤Mp< 70°C), this temperature being at least equal to the temperature of the keratin material which must receive the composition according to the invention, in particular the skin. The melting point may be measured in particular by any known method and in particular with a differential scanning calorimeter (DSC).
Preferably, the crystallizable blocks or chains of the semi-crystalline polymers represent at least approximately 30% by weight and preferably at least approximately 40% by weight relative to the total weight of each polymer. The semi-crystalline polymers comprising crystallizable blocks used according to the invention are block or multiblock polymers. They may be obtained via polymerization of monomers containing double bonds which are reactive (or which are ethylenic) or via polycondensation. When the polymers of the invention are polymers containing crystallizable side chains, they are advantageously in random or statistical form.
The semi-crystalline polymers of the invention may be of synthetic origin. Moreover, they do not comprise a polysaccharide backbone.
The semi-crystalline polymers that may be used in the invention are in particular:
- block copolymers of polyolefins with controlled crystallization,
- polycondensates of aliphatic or aromatic polyester or aliphatic/aromatic copolyester type,
- homopolymers or copolymers bearing at least one crystallizable side chain and homopolymers or copolymers bearing at least one crystallizable block in the backbone,
- homopolymers or copolymers bearing at least one crystallizable side chain, in particular containing fluoro group(s), and
- mixtures thereof.
For example, the block copolymers of polyolefins with controlled crystallization suitable for the present invention are in particular those of which the monomers are described in EP-A-0951 897.
For example, homopolymers or copolymers bearing at least one crystallizable side chain and homopolymers or copolymers bearing at least one crystallizable block in the backbone that are particularly suitable for implementing the invention are those described in particular in document US-A-5 156911-
Finally, the homopolymers or copolymers bearing at least one crystallizable side chain, in particular containing fluoro group(s), are preferably those described in document WO-A-01/19333.
In one particular embodiment, the crystallizable side chain(s) or block(s) are hydrophobic. a) Semi-crystalline polymers containing crystallizable side chains:
Mention may be made in particular of those defined in documents US-A- 5 156911 and WO-A-01/19333. They are homopolymers or copolymers comprising from 50% to 100% by weight of units resulting from the polymerization of one or more monomers bearing a crystallizable hydrophobic side chain.
These homopolymers or copolymers are of any nature, provided that they meet the conditions mentioned previously.
They can result:
- from the polymerization, in particular the free-radical polymerization, of one or more monomers containing double bond(s) which is (are) reactive, or which is (are) ethylenic, with respect to a polymerization, namely a vinyl, (meth)acrylic or allyiic group,
- from the polycondensation of one or more monomers bearing co-reactive groups (carboxylic acid, sulfonic acid, alcohol, amine or isocyanate), such as, for example, polyesters, polyurethanes, polyethers, polyureas or polyamides.
In general, these polymers are chosen in particular from homopolymers and copolymers resulting from the polymerization of at least one monomer containing crystallizable chain(s) that may be represented by the following formula:
with M representing an atom of the polymer backbone, S representing a spacer and C representing a crystallizable group.
The crystallizable chains "-S-C" may be aliphatic or aromatic, and optionally fluorinated or perfluorinated. "S" represents in particular a group (CH2)n or (CH2CH2O)n or (CH2O), which may be linear or branched or cyclic, with n being an integer ranging from 0 to 22. Preferably, "S" is a linear group. Preferably, "S" and "C" are different
When the crystallizable chains "-S-C" are hydrocarbon-based aliphatic chains, they comprise hydrocarbon-based alkyl chains containing at least 11 carbon atoms and at most 40 carbon atoms and preferably at most 24 carbon atoms. They are in particular aliphatic chains or alkyl chains containing at least 12 carbon atoms, and they are preferably C14-C24 alkyl chains. When they are fluoroalkyl or perfluoroalkyl chains, they contain at least six fluorinated carbon atoms and in particular at least 11 carbon atoms, at least six of which carbon atoms are fluorinated.
According to one particular embodiment, the invention relates to a composition for which the semi-crystalline polymer is chosen from a group comprising homopolymers and copolymers resulting from the polymerization of at least one monomer containing crystallizable chain(s), said chain being chosen from alkyl chains comprising at least 11 carbon atoms and at most 40 carbon atoms.
As examples of semi-crystalline polymers or copolymers containing crystallizable chain(s), mention may be made of those resulting from the polymerization of one or more of the following monomers: saturated alkyl (meth)acrylates with the alkyl group being C14-C24, perfluoroalkyl (meth)acrylates with a C11-C15 perfluoroalkyl group, N-alkyl(meth)acrylamides with the alkyl group being C14 to C24 with or without a fluorine atom, vinyl esters containing alkyl or perfluoro(alkyl) chains with the alkyl group being C14 to C24 (with at least 6 fluorine atoms per perfluoroalkyl chain), vinyl ethers containing alkyl or perfluoro(alkyl) chains with the alkyl group being Ct4 to C24 and at least 6 fluorine atoms per perfluoroalkyl chain, C14 to C24 alpha-olefins such as, for example,
octadecene, para-alkylstyrenes with an alkyl group containing from 12 to 24 carbon atoms, and mixtures thereof.
When the polymers result from a polycondensation, the hydrocarbon-based and/or fluorinated crystallizable chains as defined above are borne by a monomer that may be a diacicl, a diol, a diamine or a diisocyanate.
According to one embodiment, when the polymers that are the subject of the invention are copolymers, they additionally contain from 0 to 50% of groups Y resulting from the copolymerization of a monomer containing a crystallizable chain with Y which is a polar or non-polar monomer or a mixture of the two:
- when Y is a polar monomer, it is either a monomer bearing polyoxyalkylenated groups (in particular oxyethylenated and/or oxypropylenated groups), a hydroxyalkyl (meth)acrylate, for instance hydroxyethyl acrylate, (meth)acrylamide, an N-alkyl(meth)acrylamide, an N,N-dialkyl(meth)acrylamide such as, for example, N,N- cliisopropylacrylamide or N-vinylpyrrolidone (NVP), N-vinylcaprolactam, a monomer bearing at least one carboxylic acid group, for instance (meth)acrylic acid, crotonic acid, itaconic acid, maleic acid or fumaric acid, or bearing a carboxylic acid anhydride group, for instance maleic anhydride, the alkyl groups denoting a saturated group which is in particular C8 to C24, and better still C14 to C24;
- when Y is a non-polar monomer, it may be an ester of the linear, branched or cyclic alkyl (meth)acrylate type, a vinyl ester, an alkyl vinyl ether, an alpha-olefin, styrene or styrene substituted with a C1 to C10 alkyl group, for instance a-methylstyrene, the alkyl groups denoting a saturated group which is in particular Cg to C24, and better still C14 to C24.
For the purposes of the invention, the term "alkyl" is intended to mean a saturated group which is in particular C8 to C24, unless expressly mentioned, and better still C14 to C24.
According to one embodiment, when the polymers mat are subjects of the invention are copolymers, they additionally contain from 0 to 50% of groups Z resulting from the copolymerization of a monomer containing a crystallizable chain with Z which is a polar monomer or a mixture of polar monomers. In this case, Z has the same definition as the "polar Y" defined above.
Preferably, the semi-crystalline polymers containing a crystallizable side chain are alkyl (meth)acrylate or alkyl(meth)acrylamide homopolymers with an alkyl group as defined above, and in particular of C14-C24, copolymers of these monomers with a hydrophilic monomer preferably of different nature from (meth)acrylic acid, for instance N-vinylpyrrolidone or hydroxyethyl (meth)acrylate, and mixtures thereof. b) Polymers bearing in the backbone at least one crvstallizable block:
These polymers are in particular block copolymers consisting of at least 2 blocks of different chemical nature, one of which is crystalHzable.
For example, the block polymers defined in patent US-A-5 156 911 are particularly suitable.
They are, for example, block copolymers of olefin or of cycloolefin containing a crystalHzable chain, for instance those resulting from the block polymerization of:
- cyclobutene, cyclohexene, cyclooctene, norbornene (i.e. bicyclo(2,2,1)-2- heptene), 5-methylnorbornene, 5-ethylnorbornene, 5,6-dimelhylnorbornene, 5,5,6- trimethylnorbomene, 5-ethylidenenorbornene, 5-phenylnorbornene, 5-benzylnorbornene, 5-vinylnorbornene, 1,4,5,8-dimethano-1,2,3,4,4a,5,8a-octahydronaphthalene, dicyclopentadiene, or mixtures thereof,
- with ethylene, propylene, 1-butene, 3-methy1- 1-butene, 1-hexene, 4-methyl- 1-pentene, 1-octene, 1-decene or 1-eicosene, or mixtures thereof, and in particular block copoly(ethylene/norbornene)s and (ethylene/propylene/emylidene-norbomene) block terpolymers.
The polymers resulting from the block copolymerization of at least two Ci- C16, preferably C2-C12 and preferably C4-C12 a-olefins such as those mentioned above and in particular block bipolymers of ethylene and of 1 -octene may also be used.
The copolymers of interest may also be copolymers containing at least one crystalHzable block, the rest of the copolymer being amorphous (at ambient temperature). These copolymers may also contain two crystallizable blocks of different chemical nature. The preferred copolymers are those that simultaneously contain at ambient temperature a crystallizable block and an amorphous block that are both hydrophobic and lipophilic, sequentially distributed; mention may be made, for example, of polymers containing one of the crystallizable blocks and one of the amorphous blocks below:
- block that is crystallizable by nature: a) of polyester type, for instance poly(alkylene terephthalate), b) of polyolefin type, for instance polyethylenes or polypropylenes;
- amorphous and lipophilic block, for instance amorphous polyolefins or copoly(olefin)s such as poly(isobutylene), hydrogenated polybutadiene or hydrogenated poly(isoprene).
As examples of such copolymers containing a crystallizable block and a separate amorphous block, mention may be made of:
- poly(ε-caprolactone)-b-poly(butadiene) block copolymers, preferably used hydrogenated, such as those described by Nojima (Macromolecules, vol. (32), p. 3727-
3734, 1999);
- the hydrogenated block or multiblock poly(butylene terephthalate)-b- poly(isoprene) block copolymers, mentioned by Boutevin et al. (Polymer Bulletin, vol. (34), p. 117-123, 1995);
- the poly(ethylene)-b-copoly(emylene/propylene) block copolymers mentioned by Rangarajan et al. (Macromolecules, vol. (26), p. 4640-4645, 1993) et Richter et al. (Macromolecules, vol. (30), p. 1053-1068, 1997);
- the poly(ethylene)-b-poly(emylethylene) block copolymers mentioned by Hamley (Advances in Polymer Science, vol. (148), p. 113-137, 1999).
The semi-crystalline polymers of the composition of the invention may or may not be partially crosslinked, provided mat the degree of crosslinking is not detrimental to their dissolution or dispersion in the oily phase, by heating above their melting point It may then be a case of chemical crosslinking, by reaction with a multifunctional monomer during the polymerization. It may also be a case of physical crosslinking, which may then be due either to the establishment of bonds of hydrogen or dipolar type between groups borne by the polymer, for instance dipolar interactions between carboxylate ionomers, these interactions being in small amount and borne by the polymer backbone; or to a phase separation between the crystallizable blocks and the amorphous blocks, borne by the polymer.
Preferably, the semi-crystalline polymers of the composition according to the invention are not crosslinked.
According to one particular embodiment of the invention, the polymer is chosen from copolymers resulting from the polymerization of at least one monomer containing a crystallizable chain chosen from saturated C14 to C24 alkyl (meth)acrylates, C11 to C15 perfluoroalkyl (meth)acrylates, Cu to C24 N-aIkyl(meth)acrylamides with or without a fluorine atom, vinyl esters containing C14 to C24 alkyl or perfluoroalkyl chains, vinyl ethers containing C14 to C24 alkyl or perfluoroalkyl chains, C14 to C24 alpha-olefins, para-alkylstyrenes with an alkyl group containing from 12 to 24 carbon atoms, with at least one optionally fluorinated C1 to C10 monocarboxylic acid ester or amide, which may be represented by the following formula:
in which R1 is H or CH3, R represents an optionally fluorinated C1-C10 alkyl group and X represents O, NH or NR2 in which R2 represents an optionally fluorinated C1- C10 alkyl group.
According to one more particular embodiment of the invention, the polymer is derived from a monomer containing a crystallizable chain chosen from saturated C14 to C22 alkyl (meth)acrylates and even more particularly poly(stearyl acrylate)s or poly(behenyl acrylate)s.
According to one particular embodiment, the semi-crystalline polymer is chosen from homopolymers obtained by polymerization of a monomer chosen from C14- C24 alkyl acrylates and C14-C24 alkyl methacrylates and from copolymers obtained by copolymerization of a monomer chosen from C14-C24 alkyl acrylates and C14-C24 alkyl methacrylates, with a hydrophilic monomer.
As particular examples of structuring semi-crystalline polymers that may be used in the composition according to the invention, mention may be made of polymers having the INCI name Poly C10-C30 alkyl acrylate, for instance the Intelimer products from the company Air Products, for instance the product Intelimer IPA 13-1, which is a polystearyl acrylate, or the product Intelimer IPA 13-6, which is a behenyl polymer.
According to one particular embodiment, the semi-crystalline polymer is a polymer having the INCI name: Poly C10-C30 alkyl acrylate.
The Inteliraer semi-crystalline polymer IPA 13-1 NG is known for its SPF booster effects, but it is barely or not at all compatible with the conventional silicone emulsifiers and, more generally, with conventional silicone ingredients.
The semi-crystalline polymers may in particular be those described in Examples 3, 4, 5, 7, 9 and 13 of patent US-A-5 156 911 containing a -COOH group, resulting from the copolymerization of acrylic acid and of C5 to C16 alkyl (meth)acrylate and more particularly from the copolymerization:
- of acrylic acid, of hexadecyl aery late and of isodecyl acrylate in a 1/16/3 weight ratio,
- of acrylic acid and of pentadecyl acrylate in a 1/19 weight ratio,
- of acrylic acid, of hexadecyl acrylate and of ethyl acrylate in a 2.5/76.5/70 weight ratio,
- of acrylic acid, of hexadecyl acrylate and of methyl acrylate in a 5/85/10 weight ratio,
- of acrylic acid and of octadecyl methacrylate in a 2.5/97.5 weight ratio,
- of hexadecyl acrylate, of polyethylene glycol methacrylate monomethyl ether containing 8 ethylene glycol units, and of acrylic acid in an 8.5/1/0.5 weight ratio.
It is also possible to use the polymer of structure "O" from National Starch, such as that described in document US-A-5 736 125, with a melting point of 44°C, and also semi-crystalline polymers with crystallizable pendant chains comprising fluoro groups, as described in Examples 1, 4, 6, 7 and 8 of document WO-A-01/19333.
It is also possible to use the semi-crystalline polymers obtained by copolymerization of stearyl acrylate and of acrylic acid or NVP as described in document US-A-5 519 063 or EP-A-550 745, with melting points of 40°C and 38°C, respectively.
It is also possible to use the semi-crystalline polymers obtained by copolymerization of behenyl acrylate and of acrylic acid or NVP, as described in documents US-A-5 519 063 and EP-A-550 745, with melting points of 60°C and 58°C, respectively.
Preferably, the semi-crystalline polymers do not comprise any carboxylic groups.
According to one embodiment of the invention, the semi-crystalline polymer(s) may represent, within the composition, approximately 0.05% to 10% by
weight, preferably from 0.1% to 5% by weight and preferably from 0.2% to 3% by weight, relative to the total weight of the composition.
UV-screeninz agents
According to one preferred embodiment, the composition according to the invention also comprises at least one UV-screening agent.
As will be illustrated in the examples below, the inventors have noticed that the presence of at least one crosslinked silicone polymer and at least one semi-crystalline polymer, as described in the present invention, stabilizes an emulsion which comprises at least one UV-screening agent.
Any UV-screening agent known from the prior art is capable of being able to be formulated in the composition according to the present invention. For the purposes of illustration, mention may in particular be made of the following compounds, represented by their INCI names:
- para-amino benzoic acid (PABA) and derivatives thereof:
PABA,
Ethyl PABA,
Ethyl Dihydroxypropyl PABA,
Ethylhexyl Dimethyl PABA, in particular commercially available under the name Escalol 507 from the company ISP,
Glyceryl PABA,
- dibenzoylmethane derivatives:
Butyl Methoxydibenzoylmethane, in particular commercially available under the name Parsol 1789 from Hofrmann-LaRoche,
Isopropyl Dibenzoylmethane,
- salicylic acid derivatives:
Homosalate, in particular commercially available under the name Eusolex HMS from the company Rona/EM Industries,
Ethylhexyl Salicylate, in particular commercially available under the name Neo Heliopan OS from Haarmann and Reimer,
Dipropylene Glycol Salicylate, in particular commercially available under the name Dipsal from Scher,
TEA Salicylate, in particular commercially available under the name Neo Heliopan TS from Haarmann and Reimer,
- cinnamic acid derivatives:
Ethylhexyl Methoxycinnamate, in particular commercially available under the name Parsol MXC from the company Hoffmann-LaRoche,
Isopropyl Methoxycinnamate,
Isoamyl Methoxycinnamate, in particular commercially available under the name Neo Heliopan E 1000 from Haarmann and Reimer,
Cinoxate,
DEA Methoxycinnamate,
Diisopropyl Methylcinnamate,
Glyceryl Ethylhexanoate Dimethoxycinnamate,
- β,β-diphenyl acrylate derivatives:
Octocrylene, in particular commercially available under the name Uvinul N539 from BASF,
Etocrylene, in particular commercially available under the name Uvinul N35 from BASF,
- benzophenone derivatives:
Benzophenone-1, in particular commercially available under the name Uvinul 400 from BASF,
Benzophenone-2, in particular commercially available under the name Uvinul D50 from BASF,
Benzophenone-3 or Oxybenzone, in particular commercially available under the name Uvinul M40 from BASF,
Benzophenone-4, in particular commercially available under the name Uvinul
MS40 from BASF,
Benzophenone-5,
Benzophenone-6, in particular commercially available under the name Helisorb 11 from Norquay,
- other preferred UV-screening agents
- Ethylhexyl triazone, for example the product sold under the name Uvinul® T 150 by the company BASF,
- Drometrizole trisiloxane, and in particular the product sold under the name Silatrizole® by the company Rhodia,
- Bis-ethylhexyloxyphenol methoxyphenyl triazine, for instance the product sold under the name Tinosorb® by the company BASF,
- Diethylhexylbutamidotriazone, for instance the product sold under the name
Uvasorb® HEB by the company Sigma 3 V,
- Phenylbenzimidazolesulfonic acid, in particular the product sold under the name Eusolex® 232 by the company Merck,
- Terephthalylidenedicamphorsulfonic acid, in particular the product sold under the name Mexoryl® SX by the company Chimex, and
- Diemylamidohydroxybenzoylhexyl benzoate, in particular the product sold under the name Uvinul® A Plus Granular by the company BASF,
- and mixtures thereof. Adjuvants
In the context of the present invention, the composition in the form of a oil-in- water or water-in-oil emulsion may also contain at least one adjuvant chosen from the adjuvants which are customary in the cosmetics field.
These adjuvants are, for example, active ingredients, preservatives, antioxidants, complexing agents, thickeners, gelling agents, film-forming agents, surfactants, co-surfactants, moisturizing agents, solvents, fragrances, fillers, bactericides, fungicides, parasiticides, odour absorbers, pH regulators, anti-inflammatory agents, colorants (dyes and pigments), and also lipid vesicles.
The term "pigments1* should be understood as meaning white or coloured, mineral or organic particles that are insoluble in an aqueous solution, which are intended to colour and/or opacify the composition containing them.
As mineral pigments that may be used in the invention, mention may be made of titanium oxide, titanium dioxide, zirconium oxide, zirconium dioxide, cerium oxide or cerium dioxide and also zinc oxide, iron oxide or chromium oxide, ferric blue, manganese violet, ultramarine blue and chromium hydrate, and mixtures thereof.
It may also be a pigment having a structure that may be, for example, of sericite/brown iron oxide/titanium dioxide/silica type. Such a pigment is sold, for example,
under the reference Coverleaf NS or JS by the company Chemicals and Catalysts, and has a contrast ratio in the region of 30.
They may also be pigments having a structure that may be, for example, of silica microsphere type containing iron oxide. An example of a pigment having this structure is the product sold by the company Miyoshi under the reference PC Ball PC-LL- 100 P, this pigment consisting of silica microspheres containing yellow iron oxide.
Advantageously, the pigments in accordance with the invention are iron oxides and/or titanium dioxides.
The amounts of these various adjuvants are those conventionally used in the field under consideration, and for example from 0.01% to 20% of the total weight of the composition. These adjuvants, depending on their nature, can be introduced into the oily phase, into the aqueous phase and/or into lipid vesicles.
These adjuvants and the concentrations thereof should be such that they do not modify the property desired for the composition of the invention.
2/Use
The compositions of the invention can be used in any cosmetic or dermatological application, for example in the cosmetics industry for caring for keratin materials, which includes any cosmetic application for caring for the skin, the hair, the scalp, the eyelashes, the eyebrows, the nails or the mucous membranes, for instance the lips.
In particular, the compositions according to the invention can be part of the production of protective, treatment or care products for the face, for the hands or for the body, as products for cleansing the skin, in particular of the face or of the body, as makeup products, for example foundations, or as hair products.
The cosmetic compositions according to the invention have applications in a large number of cosmetic treatments for keratin materials, and more especially the skin, in particular for obtaining a feeling of softness of the skin and a silky effect. By virtue of its pleasantness and its effects, the composition of the invention is particularly suitable for treating skin showing imperfections and also dehydrated, rough or sensitive skin.
Thus, a subject of the present invention is the cosmetic use of a composition as defined above, for caring for the skin, in particular dehydrated skin or skin comprising imperfections.
A subject of the present invention is also the cosmetic use of a composition as defined above, for caring for the hair, in particular for conferring thereon a silky appearance.
A composition according to the invention may be in various galenical forms conventionally used for topical applications and in particular in the form of dispersions of the serum type, emulsions of liquid or semi-liquid consistency of the milk type, obtained by dispersing an oily phase in an aqueous phase (O/W) or vice versa (W/O), or suspensions or emulsions of soft, semi-solid or solid consistency of the cream or gel type, or alternatively multiple emulsions (W/O/W or O/W/O), microemulsions, vesicular dispersions of ionic and/or nonionic type. These compositions are prepared according to the usual methods.
In addition, the compositions used according to the invention may be more or less fluid and may have the appearance of a gel, of a white or coloured cream, an ointment, a milk, a serum, a paste or a foam.
According to another particular embodiment, the composition according to the invention is in the form of a water-in-oil emulsion comprising a continuous oily phase and an aqueous phase dispersed in said oily phase, or in the form of an oil-in-water emulsion comprising a continuous aqueous phase and an oily phase dispersed in said aqueous phase.
3/Cosmetic method
A subject of the present invention is also a cosmetic method for attenuating the visible or tactile irregularities of the surface of the skin, comprising a topical administration of a composition according to the invention to the skin and/or the lips.
Indeed, the good penetration and the feeling of softness of the skin, which are obtained after application of a composition according to the invention, reinforce the consumer's sensation of skin which has a smooth and uniform appearance.
Likewise, a subject of the present invention is also a cosmetic method for improving the appearance of the hair and/or the nails, comprising a topical administration of a composition according to the invention to the hair and/or the nails.
The topical application of a composition makes it possible to reinforce the silky appearance of the hair and thus reduces the rough, coarse, brittle appearance.
According to another aspect, the topical administration can be carried out at a rate of at least once a day, of at least once every 2 days, of once every 3 days, or of once a week. The term "at least once a day" encompasses twice a day, 3 times a day, 4 times a day.
Thus, as will be shown by the examples below, the combination of a crosslinked silicone polymer as described in the invention with a semi-crystalline polymer, in care, makeup or screening emulsions, makes it possible to optimize the feelings of softness, comfort, penetration and persistence.
The examples that follow will allow the invention to be understood more clearly, without, however, being limiting in nature. The raw materials are referred to by their chemical or INCI name. The amounts indicated are given as % by weight of raw materials, unless otherwise mentioned.
EXAMPLES
1) Materials and methods
1. 1) Process for preparing compositions according to the invention The aqueous phase is prepared in a Rayneri mixer, by dissolving hydrophilic adjuvant(s) and or water-miscible solvents) in water (at the required temperature), and then a hydrophilic gelling agent is added with stirring at a temperature of approximately 70°C until the gel is homogeneous. The fatty phase is then homogenized, at a temperature suitable for obtaining a homogeneous liquid phase. When the mixtures of the two phases are homogeneous, an emulsion is conventionally produced by adding the aqueous phase to the oily phase with stirring in a Rayneri mixer. The emulsion is then cooled with stirring until a homogeneous smooth cream is obtained.
1.2) Evaluation of the cosmetic properties of the emulsions
The cosmetic properties were evaluated according to the following protocol. The cosmetic properties on application are evaluated, monadically, by a panel of experts trained in the description of care products. The sensory evaluation of the care products by this panel is performed as follows: the products are packaged in opaque jars or pump-
dispenser bottles depending on the viscosity of the products. Within the same session, the samples are presented in random order to each panellist.
In each case, 15 experts evaluated the comfort during application to the skin and after penetration.
The parameter is evaluated on a 5-level scale: no, little, medium, quite, very. A score was assigned to each level: no (0), little (1), medium (2), quite (3) and very (4). Subsequently, the scores assigned by each of the 15 experts are added so as to obtain an overall score.
A ratio between the score obtained for the compositions according to the invention and the score obtained for the comparative compositions was calculated. A ratio greater than 1.25 was considered to be statistically significant for the parameter under consideration.
1.3) Stability
The immediate stability at ambient temperature and the stability after 2 months of storage under different temperature conditions, i.e. 4°C, ambient temperature (25°C) and 45°C, were evaluated.
For the water-in-oil emulsions, a cycle stability was performed (10 cycles -20/+20°C).
2) Results
2.1) Comparative Example 1: Screening water-in-oil emulsions
Example 1 illustrates the evaluation of the stability properties of an emulsion according to the invention in comparison with an emulsion of which the formulation is adapted from document FR 2 912 651.
Table 1; formulations of water-in-oil emulsions 1 and 2 (as % by weight relative to the total weight of the composition)
KSG-210 from Shin Etsu, (25% of active material in dmiethicone); EL-7040 from Dow Corning (HSOEB, 18% of active material in CAPRYLYL METHICONE); 3 Sunscreens; 4 INTELIMER IPA 13-1; 5 The content is represented as % by weight of raw material relative to the total weight of the composition, which corresponds to a weight of active material of 3.24% by weight relative to the total weight of the composition; 6 Luvigel EM from BASF.
In conclusion: the screening composition of the invention, in which the crosslinked silicone polymer (PEG-12 Dimethicone/PPG-20 Crosspolymer) is used as an emulsifying elastomer, is more stable compared with the screening composition of the comparative example in which KSG210 is used as an emulsifying elastomer.
2.2) Comparative example 2 - Screening compositions with lipophilic screening agents
In order to demonstrate the advantage of the combination, the stability and the cosmetic properties of 2 water-in-oil emulsions containing the combination of crosslinked silicone polymer (PEG-12 Dimethicone/PPG-20 Crosspolymer) and semi-crystalline polymer (Poly C10-C30 Alkyl acrylate) (emulsions 4 and 5) were compared with the same parameters of an emulsion not containing the semi-crystalline polymer (emulsion 3).
Table 2: formulations of water-in-oil emulsions 3.4 and 5 (as % by weight relative to the total weight of the composition)
1 EL-7040 from Dow Corning (HSOEB, 18% of active material in CAPRYLYL METfflCONE); 2 Sunscreens; 3 INTELIMER IPA 13-1; 4 The content is represented as % by weight of raw material relative to the total weight of the composition, which corresponds to a weight of active material of 3.24% by weight relative to the total weight of the composition; 5 Rheoluxe 811 from Elementis. a) Evaluation of the performance levels of the water-in-oil emulsions W/O 3, W/O 4 and W/0 5
For each of the 3 compositions, the following were evaluated:
- the immediate stability at ambient temperature and the stability after 2 months of storage at 45°C;
- the application, comfort and persistence qualities and, in the presence of screening agents, a good SPF effect after application to the skin.
Table 3; stability of water-in-oil emulsions 3. 4 and 5
With regard to the stability parameter, the screening compositions according to the invention, in which the crosslinked silicone polymer of HSOEB type (PEG- 12 Dimethicone/PPG-20 Crosspolymer) is used as an emulsifying elastomer and comprising a semi-crystalline polymer (Poly C10-C30 Alkyl acrylate), are more stable than the composition of the comparative example not containing semi-crystalline polymer (Poly C10-C30 Alkyl acrylate).
With regard to the protective index performance parameter, the use of the semi-crystalline polymer (Intelimer IPA 13-1 NG) in combination with the crosslinked silicone polymer (PEG-12 Dimethicone/PPG-20 Crosspolymer), i.e. emulsions 4 and 5, makes it possible to significantly increase the SPF performance of the product compared with a formulation without semi-crystalline polymer (emulsion 3), without degrading the sensory effect. b) Evaluation of the sensory effect:
Table 4: cosmetic performance levels of water-in-oil emulsions 3. 4 and 5
With the addition of the semi-crystalline polymer of Intelimer IPA 13-1 NG type in a composition comprising a crosslinked silicone polymer (PEG-12 Dimethicone/PPG-20 Crosspolymer) makes possible to guarantee a more uniform application on the skin. The screening emulsions according to the invention are also very fresh on application and very
nourishing while at the same time retaining the qualities of softness, both on application and after application.
Claims
1. Composition in the form of an emulsion comprising at least:
(i) one aqueous phase,
(ii) one oily phase,
(iii) one silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain, and
(iv) one semi-crystalline polymer.
2. Composition according to Claim 1, which is a cosmetic composition, preferably a cosmetic composition for topical application.
3. Composition according to either of Claims 1 and 2, characterized in that the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain is present in the form of a silicone elastomer gel, said silicone elastomer gel comprising:
- 2% to 95% by weight, relative to the total weight of the silicone elastomer gel, of an organic silicone elastomer, obtained by reacting:
A) an organohydrogenosiloxane comprising siloxy units of average formula: (R1 3SiO0.5)v (R2 2SiO)x (R2HSiO)y in which:
- R1 represents a hydrogen or R2,
- R2 represents a monovalent hydrocarbyl group,
- v≥ 2, x≥ 0, y≥≥ 2,
B) a first polyoxyalkylene having the average formula:
R3O-[(C2H4O)c(C3H6O)d(C4H8O)e]-R3
in which:
- R3 is a monovalent unsaturated aliphatic hydrocarbon- based group containing from 2 to 12 carbon atoms,
- c ranges from 0 to 50, d ranges from 0 to 100, e ranges from 0 to 100, with the condition that the ratio of (d+e)/(c+d+e) is greater than 0.5,
C) a hydrosilylation catalyst,
D) a second polyoxyalkylene having the average formula:
R3O[(C2H4O)c' (C3H6O)d' (C4H8O)e]-R4
in which:
- R3 represents a monovalent unsaturated aliphatic hydrocarbon-based group containing from 2 to 12 carbon atoms,
- c' represents a value greater than 4, d' and e represent a value which can range from 0 to 100,
- R4 represents a hydrogen atom, an acyl group, or a monovalent hydrocarbon-based group containing 1 to 8 carbon atoms,
in which said organic silicone elastomer comprises from 2% to 25% of ethylene oxide units,
- 5% to 98% by weight, relative to the total weight of the silicone elastomer gel, of a hydrophobic liquid carrier.
4. Composition according to one of Claims 1 to 3, characterized in that the emulsion is chosen from an O/W emulsion and a W/O emulsion, preferably a W/O emulsion.
5. Composition according to one of Claims 1 to 4, characterized in that the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain represents approximately 0.01% to 10% by weight, preferably approximately 0.15% to 7% by weight, preferably approximately 0.18% to 5.4% by weight, preferably approximately 0.36% to 3.6% by weight, relative to the total weight of the composition.
6. Composition according to one of Claims 1 to 5, characterized in that the polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain is a silicone polymer crosslinked with a polyoxypropylene chain, preferably having from 4 to 50 and better still from 10 to 30 propylene oxide units, and comprising at least one pendant polyoxyethylene chain, preferably having from 4 to 20 ethylene oxide units.
7. Composition according to one of Claims 1 to 6, characterized in that the silicone polymer crosslinked with at least one polyoxyalkylene chain and comprising at least one pendant polyoxyalkylene chain is a polyoxyethylenated dimethicone polymer, in
particular having 12 ethylene oxide units, crosslinked with bis-allyl polypropylene glycol, in particular having 20 propylene oxide units.
S. Composition according to one of Claims 1 to 7, characterized in that the semi-crystalline polymer represents approximately 0.05% to 10% by weight, preferably approximately 0.1% to 5% by weight, preferably approximately 0.2% to 3% by weight, relative to the total weight of the composition.
9. Composition according to one of Claims 1 to 8, characterized in that the semi-crystalline polymer is chosen from a group comprising homopolymers and copolymers resulting from the polymerization of at least one monomer containing crystallizable chain(s), said chain being chosen from alkyl chains comprising at least 11 carbon atoms and at most 40 carbon atoms.
10. Composition according to one of Claims 1 to 9, characterized in that the semi-crystalline polymer is chosen from homopolymers obtained by polymerization of a monomer chosen from C14-C24 alkyl acrylates and C14-C24 alkyl methacrylates and from copolymers obtained by copolymerization of a monomer chosen from C14-C24 alkyl acrylates and C14-C24 alkyl methacrylates, with a hydrophilic monomer.
11. Composition according to one of Claims 1 to 10, characterized in that the semi-crystalline polymer is chosen from saturated C14 to C22 alkyl (meth)acrylates and preferably from poly(stearyl acrylate)s or poly(behenyl acrylate)s.
12. Composition according to one of Claims 1 to 11, characterized in that the water-in-oil W/O emulsion comprises an oily phase representing approximately 0.5% to 50% by weight, preferably approximately 10% to 35% by weight, relative to the total weight of the composition.
13. Composition according to one of Claims 1 to 12, characterized in that the composition also comprises at least one UV-screening agent.
14. Composition according to one of Claims 1 to 13, characterized in that the composition also comprises at least one adjuvant, in particular chosen from active ingredients, preservatives, antioxidants, complexing agents, thickeners, gelling agents, film-forming agents, surfactants, co-surfactants, moisturizing agents, solvents, fragrances, fillers, bactericides, fungicides, parasiticides, odour absorbers, pH regulators, antiinflammatory agents, colorants (dyes and pigments), and lipid vesicles.
15. Cosmetic use of a composition according to one of Claims 1 to 14, for caring for keratin materials, preferably the skin, the lips, the hair and the nails.
16. Method for the cosmetic treatment of keratin materials, comprising a topical administration of a composition according to one of Claims 1 to 14.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1457060 | 2014-07-22 | ||
FR1457060A FR3024034A1 (en) | 2014-07-22 | 2014-07-22 | EMULSIONS STABILIZED BY A RETICULATED SILICONE POLYMER AND A SEMI-CRYSTALLINE POLYMER |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2016012515A2 true WO2016012515A2 (en) | 2016-01-28 |
WO2016012515A3 WO2016012515A3 (en) | 2016-06-23 |
Family
ID=51610342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2015/066796 WO2016012515A2 (en) | 2014-07-22 | 2015-07-22 | Emulsions stabilized with a crosslinked silicone polymer and a semi-crystalline polymer |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3024034A1 (en) |
WO (1) | WO2016012515A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019119077A1 (en) * | 2017-12-19 | 2019-06-27 | L'oreal | Sun care composition |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017167667A1 (en) * | 2016-03-31 | 2017-10-05 | L'oreal | Aqueous emulsion comprising a silicone-based dendritic polymer, a silicone gum and a semi-crystalline polymer or a wax and treatment of the lips |
FR3049457B1 (en) * | 2016-03-31 | 2018-05-11 | L'oreal | AQUEOUS EMULSION COMPRISING A SILICONE DENDRITIC POLYMER, A SILICONE GUM AND A SEMI-CRYSTALLINE POLYMER, AND A METHOD OF TREATING THE LIP USING THE SAME |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2912651A1 (en) * | 2007-02-21 | 2008-08-22 | Oreal | W / O EMULSION FOR SKIN CARE. |
-
2014
- 2014-07-22 FR FR1457060A patent/FR3024034A1/en not_active Withdrawn
-
2015
- 2015-07-22 WO PCT/EP2015/066796 patent/WO2016012515A2/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019119077A1 (en) * | 2017-12-19 | 2019-06-27 | L'oreal | Sun care composition |
Also Published As
Publication number | Publication date |
---|---|
FR3024034A1 (en) | 2016-01-29 |
WO2016012515A3 (en) | 2016-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101485615B (en) | Oil-in-water type cosmetic emulsion | |
EP2094227B1 (en) | High gloss gel-based lipstick | |
EP3532022B1 (en) | Composition comprising at least two fatty acid esters of (poly)glycerol, and use thereof in cosmetics | |
KR102002099B1 (en) | Cosmetic compositions in the form of water-in-oil emulsions including a jasmonic acid derivative | |
EP3709953B1 (en) | Composition comprising a fatty phase, a lipophilic polymer and a volatile hydrocarbon-based oil | |
KR20180005159A (en) | Matte cosmetic composition | |
ES2283957T3 (en) | COMPOSITION FOR TOPICAL APPLICATION CONTAINING AN ELASTOMERO ORGANOPOLISILOXAN AND A WATERPROOF DISPERSION OF A SILICONE BLOCK COPOLYMER. | |
US12138340B2 (en) | Composition comprising pigment coated with isopropyl titanium triisostearate | |
EP2548548A1 (en) | Hair cosmetic composition | |
US20090291056A1 (en) | Aqueous Based Cosmetic Compositions With Clear Or Translucent Non-Amidated Structuring Agent | |
KR20160008548A (en) | Cosmetic composition comprising a silicone oil and polymethylmethacrylate particles | |
CN105451819A (en) | Composition comprising a superabsorbent polymer and an organopolysiloxane elastomer | |
KR102292946B1 (en) | Cosmetic composition comprising water, silicone resin and non-volatile silicone oil and method of using the same | |
KR102291906B1 (en) | A composition in the form of a direct emulsion comprising a silicone resin and a non-volatile silicone oil, and a method of using the same | |
WO2019122158A1 (en) | Composition in the form of an emulsion comprising a silicone resin and an amino silicone oil, and process using the same | |
US20130259814A1 (en) | Long wear cosmetic compositions containing poss thermoplastic elastomers | |
WO2016012515A2 (en) | Emulsions stabilized with a crosslinked silicone polymer and a semi-crystalline polymer | |
WO2016012513A1 (en) | Emulsions comprising at least one filler and stabilized by a crosslinked silicone polymer | |
US11534386B2 (en) | Emulsion comprising an anionic acrylic copolymer and a lipophilic polymer | |
US10532010B2 (en) | Volumizing mascara compositions | |
WO2013117550A2 (en) | Cosmetic composition comprising silica aerogel particles and a semicrystalline polymer | |
EP2174691A1 (en) | Cosmetic core stick with a water based hard core part | |
GB2422605A (en) | Ionic thickening agent for compositions | |
WO2010105149A1 (en) | Ester gels, methods of manufacture, and uses thereof | |
KR20210006413A (en) | Emulsion containing silicone resin, liquid polyol and pigment, preparation of emulsion, and method of using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15754124 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15754124 Country of ref document: EP Kind code of ref document: A2 |